JP2005537255A - 新規三環式スピロピペリジンまたはスピロピロリジン - Google Patents
新規三環式スピロピペリジンまたはスピロピロリジン Download PDFInfo
- Publication number
- JP2005537255A JP2005537255A JP2004519472A JP2004519472A JP2005537255A JP 2005537255 A JP2005537255 A JP 2005537255A JP 2004519472 A JP2004519472 A JP 2004519472A JP 2004519472 A JP2004519472 A JP 2004519472A JP 2005537255 A JP2005537255 A JP 2005537255A
- Authority
- JP
- Japan
- Prior art keywords
- spiro
- oxy
- benzofuran
- piperidin
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JUXAVSAMVBLDKO-UHFFFAOYSA-N 1-(1-azabicyclo[2.2.2]octan-3-yl)-3-[3-(1h-indol-3-yl)-1-oxo-1-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylpropan-2-yl]urea Chemical compound C1N(CC2)CCC2C1NC(=O)NC(C(=O)N1CCC2(C3=CC=CC=C3CC2)CC1)CC1=CNC2=CC=CC=C12 JUXAVSAMVBLDKO-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 26
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 9
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 5
- -1 cyano, hydroxyl Chemical group 0.000 claims description 339
- 150000001875 compounds Chemical class 0.000 claims description 309
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 74
- 229910052757 nitrogen Inorganic materials 0.000 claims description 73
- 239000000460 chlorine Substances 0.000 claims description 67
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 66
- 125000001424 substituent group Chemical group 0.000 claims description 52
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 51
- 125000000623 heterocyclic group Chemical group 0.000 claims description 50
- 229920006395 saturated elastomer Polymers 0.000 claims description 46
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 45
- 229910052736 halogen Inorganic materials 0.000 claims description 43
- 150000002367 halogens Chemical class 0.000 claims description 43
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 39
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 38
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 35
- 125000005842 heteroatom Chemical group 0.000 claims description 34
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 33
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 33
- 229910052717 sulfur Inorganic materials 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 32
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 31
- 239000012453 solvate Substances 0.000 claims description 26
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 25
- 229910052760 oxygen Inorganic materials 0.000 claims description 25
- 239000001301 oxygen Substances 0.000 claims description 25
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 24
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 24
- 239000011737 fluorine Substances 0.000 claims description 23
- 229910052731 fluorine Inorganic materials 0.000 claims description 23
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 22
- 239000011593 sulfur Substances 0.000 claims description 22
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 21
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 21
- 229910052801 chlorine Inorganic materials 0.000 claims description 21
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 21
- 125000004122 cyclic group Chemical group 0.000 claims description 19
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims description 17
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 17
- LSBDFXRDZJMBSC-UHFFFAOYSA-N Amide-Phenylacetic acid Natural products NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 claims description 16
- 125000004043 oxo group Chemical group O=* 0.000 claims description 13
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 12
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 11
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 claims description 11
- 125000004434 sulfur atom Chemical group 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 11
- 208000006673 asthma Diseases 0.000 claims description 10
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 125000006239 protecting group Chemical group 0.000 claims description 8
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 7
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 7
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 6
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 5
- VERICJRMEJIMFH-LBOXEOMUSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CC2(OC3=CC=C(Cl)C=C3C2)CC1 VERICJRMEJIMFH-LBOXEOMUSA-N 0.000 claims description 5
- XWGQUYRQAQAXPX-VWLOTQADSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxy-2-methylpropoxy]-n-cyclopropyl-4-hydroxybenzamide Chemical compound C([C@](O)(C)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)NC1CC1 XWGQUYRQAQAXPX-VWLOTQADSA-N 0.000 claims description 5
- KZJPBYOFBQXPKM-SFHVURJKSA-N 2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 KZJPBYOFBQXPKM-SFHVURJKSA-N 0.000 claims description 5
- ZIEHNPDOABMLSY-SANMLTNESA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxy-2-methoxypropoxy]-n-cyclopropyl-4-hydroxybenzamide Chemical compound C([C@@](O)(OC)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)NC1CC1 ZIEHNPDOABMLSY-SANMLTNESA-N 0.000 claims description 5
- URVPWPSIVXZUQG-SFHVURJKSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 URVPWPSIVXZUQG-SFHVURJKSA-N 0.000 claims description 5
- JDTCZRQCZFSKET-RTWAWAEBSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CC[C@@H](O)C1 JDTCZRQCZFSKET-RTWAWAEBSA-N 0.000 claims description 5
- JDTCZRQCZFSKET-SFTDATJTSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CC[C@H](O)C1 JDTCZRQCZFSKET-SFTDATJTSA-N 0.000 claims description 5
- HYXOPHKTCBTUBR-NRFANRHFSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-morpholin-4-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCOCC1 HYXOPHKTCBTUBR-NRFANRHFSA-N 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- RBWHUCBCXNBGJS-IBGZPJMESA-N n-(2-aminoethyl)-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzamide Chemical compound NCCNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RBWHUCBCXNBGJS-IBGZPJMESA-N 0.000 claims description 5
- BHJHNTAOLMSNBP-DEOSSOPVSA-N n-[2-[(2s)-2-hydroxy-2-methyl-3-spiro[1h-2-benzofuran-3,4'-piperidine]-1'-ylpropoxy]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@@](C)(O)CN2CCC3(CC2)C2=CC=CC=C2CO3)=C1 BHJHNTAOLMSNBP-DEOSSOPVSA-N 0.000 claims description 5
- WCRBPIRGZTVJNT-IBGZPJMESA-N n-[2-[(2s)-2-hydroxy-3-spiro[1h-2-benzofuran-3,4'-piperidine]-1'-ylpropoxy]-5-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC(C(F)(F)F)=CC=C1OC[C@@H](O)CN1CCC2(C3=CC=CC=C3CO2)CC1 WCRBPIRGZTVJNT-IBGZPJMESA-N 0.000 claims description 5
- UPJKIFHQLCQWAV-BQAIUKQQSA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxy-2-methylpropoxy]-4-hydroxyphenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@](C)(O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 UPJKIFHQLCQWAV-BQAIUKQQSA-N 0.000 claims description 5
- QWHNOQNYFNTBJI-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1 QWHNOQNYFNTBJI-IBGZPJMESA-N 0.000 claims description 5
- YPUJWISVZVZVNU-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 YPUJWISVZVZVNU-IBGZPJMESA-N 0.000 claims description 5
- MBDUWSHERUMDHN-KRWDZBQOSA-N n-[4-chloro-2-[(2s)-2-hydroxy-3-(3-oxospiro[2-benzofuran-1,4'-piperidine]-1'-yl)propoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C=C1OC[C@@H](O)CN1CCC2(C3=CC=CC=C3C(=O)O2)CC1 MBDUWSHERUMDHN-KRWDZBQOSA-N 0.000 claims description 5
- AKXRCRQXUDAPSH-IBGZPJMESA-N n-[4-hydroxy-2-[(2s)-2-hydroxy-3-[5-(trifluoromethyl)spiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl]propoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(C=C3C2)C(F)(F)F)CC1 AKXRCRQXUDAPSH-IBGZPJMESA-N 0.000 claims description 5
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 claims description 5
- PNNRXXHZGCWCBM-SFTDATJTSA-N (3s)-n-[5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=C(Cl)C=C1NC(=O)N1CC[C@H](O)C1 PNNRXXHZGCWCBM-SFTDATJTSA-N 0.000 claims description 4
- IXVPGNICPGFZNM-FERBBOLQSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methylbenzoic acid;hydrochloride Chemical compound Cl.CC1=CC=C(C(O)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1 IXVPGNICPGFZNM-FERBBOLQSA-N 0.000 claims description 4
- SXFCZOCWXLILSQ-FQEVSTJZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopropyl-4-fluorobenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(F)=CC=C1C(=O)NC1CC1 SXFCZOCWXLILSQ-FQEVSTJZSA-N 0.000 claims description 4
- QUWFBAJQLUHXBF-FQEVSTJZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopropyl-4-hydroxybenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)NC1CC1 QUWFBAJQLUHXBF-FQEVSTJZSA-N 0.000 claims description 4
- MVACDKPCOURBQW-FQEVSTJZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopropyl-4-methoxybenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(OC)=CC=C1C(=O)NC1CC1 MVACDKPCOURBQW-FQEVSTJZSA-N 0.000 claims description 4
- JUUHNDDXTYAFHK-FQEVSTJZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopropylbenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1C(=O)NC1CC1 JUUHNDDXTYAFHK-FQEVSTJZSA-N 0.000 claims description 4
- NNGXCRLIOIFUEJ-KRWDZBQOSA-N 2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]benzoic acid Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC=CC=C1C(O)=O NNGXCRLIOIFUEJ-KRWDZBQOSA-N 0.000 claims description 4
- QUWJHBYTQZGSSF-SFTDATJTSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-fluorophenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(F)=CC=C1C(=O)N1CC[C@H](O)C1 QUWJHBYTQZGSSF-SFTDATJTSA-N 0.000 claims description 4
- FKQBADNKWDHGBH-LMOVPXPDSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-fluorophenyl]urea;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 FKQBADNKWDHGBH-LMOVPXPDSA-N 0.000 claims description 4
- XVTZPWHNTXWCMM-QFIPXVFZSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-hydroxypiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCC(O)CC1 XVTZPWHNTXWCMM-QFIPXVFZSA-N 0.000 claims description 4
- GLNPMXYDUHTRSI-CMXBXVFLSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(4r)-4-hydroxy-1,2-oxazolidin-2-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1C[C@@H](O)CO1 GLNPMXYDUHTRSI-CMXBXVFLSA-N 0.000 claims description 4
- GLNPMXYDUHTRSI-FKLPMGAJSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(4s)-4-hydroxy-1,2-oxazolidin-2-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1C[C@H](O)CO1 GLNPMXYDUHTRSI-FKLPMGAJSA-N 0.000 claims description 4
- AUMJGPWKEMYEDA-ZYZRXSCRSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCC(C(F)(F)F)C1 AUMJGPWKEMYEDA-ZYZRXSCRSA-N 0.000 claims description 4
- BVUKMGGCFWNCBI-DQUNLGLBSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[3-hydroxy-3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCC(O)(C(F)(F)F)C1 BVUKMGGCFWNCBI-DQUNLGLBSA-N 0.000 claims description 4
- DIEQQIKEZQRHHN-QFIPXVFZSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-piperidin-1-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCCCC1 DIEQQIKEZQRHHN-QFIPXVFZSA-N 0.000 claims description 4
- YSKHHXOZIGRPPI-NRFANRHFSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-pyrrolidin-1-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCCC1 YSKHHXOZIGRPPI-NRFANRHFSA-N 0.000 claims description 4
- NYOCRVNAUBKUMS-LMOVPXPDSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]urea;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 NYOCRVNAUBKUMS-LMOVPXPDSA-N 0.000 claims description 4
- QHFAQQDHAJFUOF-NQCNTLBGSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methylphenyl]-[2-(hydroxymethyl)morpholin-4-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(C)=CC=C1C(=O)N1CCOC(CO)C1 QHFAQQDHAJFUOF-NQCNTLBGSA-N 0.000 claims description 4
- TZGSCSISEHIMFN-LMOVPXPDSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]urea;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 TZGSCSISEHIMFN-LMOVPXPDSA-N 0.000 claims description 4
- MATCGWPKJODSCF-SFTDATJTSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CC[C@H](O)C1 MATCGWPKJODSCF-SFTDATJTSA-N 0.000 claims description 4
- WOAIGBULHVQADQ-SFTDATJTSA-N [4-fluoro-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1)OC1=CC(F)=CC=C1C(=O)N1CC[C@H](O)C1 WOAIGBULHVQADQ-SFTDATJTSA-N 0.000 claims description 4
- ISSZIQZCXJTNET-SFTDATJTSA-N [4-hydroxy-2-[(2s)-2-hydroxy-3-[5-(trifluoromethyl)spiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl]propoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(C=C3C2)C(F)(F)F)CC1)OC1=CC(O)=CC=C1C(=O)N1CC[C@H](O)C1 ISSZIQZCXJTNET-SFTDATJTSA-N 0.000 claims description 4
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- 125000005059 halophenyl group Chemical group 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- FRCSGPIZMKPBKK-NRFANRHFSA-N n-(2-acetamidoethyl)-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzamide Chemical compound CC(=O)NCCNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 FRCSGPIZMKPBKK-NRFANRHFSA-N 0.000 claims description 4
- DXKZFWGECAGFGG-GMAHTHKFSA-N n-[(3s)-1-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoyl]pyrrolidin-3-yl]acetamide Chemical compound C1[C@@H](NC(=O)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 DXKZFWGECAGFGG-GMAHTHKFSA-N 0.000 claims description 4
- YAWLGJHDNXUORF-FTBISJDPSA-N n-[2-[(2s)-3-(5-chlorospiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl)-2-hydroxy-2-methylpropoxy]-4-hydroxyphenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@](C)(O)CN1CCC2(OC3=CC(Cl)=CC=C3O2)CC1 YAWLGJHDNXUORF-FTBISJDPSA-N 0.000 claims description 4
- WUBCKHPJCVXYKE-LMOVPXPDSA-N n-[2-[(2s)-3-(5-chlorospiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC(Cl)=CC=C3O2)CC1 WUBCKHPJCVXYKE-LMOVPXPDSA-N 0.000 claims description 4
- ZNGBERDSXISIEA-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-fluorophenyl]acetamide Chemical compound CC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 ZNGBERDSXISIEA-IBGZPJMESA-N 0.000 claims description 4
- JWMBFLXRBZIVNF-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]acetamide Chemical compound CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 JWMBFLXRBZIVNF-IBGZPJMESA-N 0.000 claims description 4
- QCVWSCIVKHXNQQ-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-5-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC(C(F)(F)F)=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 QCVWSCIVKHXNQQ-IBGZPJMESA-N 0.000 claims description 4
- OVABPWVCGOCAMY-MBSDFSHPSA-N n-[2-[(2s)-3-[(2r)-5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine]-1'-yl]-2-hydroxypropoxy]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@@H](O)CN2C[C@@]3(CC2)OC2=CC=C(Cl)C=C2C3)=C1 OVABPWVCGOCAMY-MBSDFSHPSA-N 0.000 claims description 4
- QNIANZNXECVERE-AVRDEDQJSA-N n-[2-[(2s)-3-[(2r)-5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine]-1'-yl]-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1C[C@]2(OC3=CC=C(Cl)C=C3C2)CC1 QNIANZNXECVERE-AVRDEDQJSA-N 0.000 claims description 4
- PGCILCNQVYITIO-IBGZPJMESA-N n-[4-chloro-2-[(2s)-2-hydroxy-3-spiro[1h-2-benzofuran-3,4'-piperidine]-1'-ylpropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C=C1OC[C@@H](O)CN1CCC2(C3=CC=CC=C3CO2)CC1 PGCILCNQVYITIO-IBGZPJMESA-N 0.000 claims description 4
- LHDARWZBURWGMK-FTBISJDPSA-N n-[4-hydroxy-2-[(2s)-2-hydroxy-2-methyl-3-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-ylpropoxy]phenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@](C)(O)CN1CCC2(OC3=CC=CC=C3O2)CC1 LHDARWZBURWGMK-FTBISJDPSA-N 0.000 claims description 4
- LSLJDIFAMHJEEY-LMOVPXPDSA-N n-[4-hydroxy-2-[(2s)-2-hydroxy-3-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-ylpropoxy]phenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=CC=C3O2)CC1 LSLJDIFAMHJEEY-LMOVPXPDSA-N 0.000 claims description 4
- ZDPXIQPQSZSLHW-IBGZPJMESA-N n-[5-chloro-2-[(2s)-2-hydroxy-3-spiro[1h-2-benzofuran-3,4'-piperidine]-1'-ylpropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC(Cl)=CC=C1OC[C@@H](O)CN1CCC2(C3=CC=CC=C3CO2)CC1 ZDPXIQPQSZSLHW-IBGZPJMESA-N 0.000 claims description 4
- PRTIJBBCISBKOZ-IBGZPJMESA-N n-[5-chloro-2-[(2s)-3-(5-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC(Cl)=CC=C1OC[C@@H](O)CN1CCC2(C3=CC(Cl)=CC=C3CO2)CC1 PRTIJBBCISBKOZ-IBGZPJMESA-N 0.000 claims description 4
- SJIIISGWUGPUFO-SFHVURJKSA-N n-[5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxyphenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1NC(C)=O SJIIISGWUGPUFO-SFHVURJKSA-N 0.000 claims description 4
- 229940124530 sulfonamide Drugs 0.000 claims description 4
- 150000003456 sulfonamides Chemical class 0.000 claims description 4
- OGGFAKFIFDUNLG-SFTDATJTSA-N (3s)-n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1NC(=O)N1CC[C@H](O)C1 OGGFAKFIFDUNLG-SFTDATJTSA-N 0.000 claims description 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 3
- AHLDOVOWZZYTNF-FERBBOLQSA-N 1-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-3-methylsulfonylurea;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CS(=O)(=O)NC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 AHLDOVOWZZYTNF-FERBBOLQSA-N 0.000 claims description 3
- HAWQASKWLVVMOW-FQEVSTJZSA-N 2-[(2s)-3-(5-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopropyl-4-fluorobenzamide Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC(Cl)=CC=C1CO2)OC1=CC(F)=CC=C1C(=O)NC1CC1 HAWQASKWLVVMOW-FQEVSTJZSA-N 0.000 claims description 3
- ZKHRLGPQRCCEIM-KRWDZBQOSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoic acid Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(O)=O ZKHRLGPQRCCEIM-KRWDZBQOSA-N 0.000 claims description 3
- CNNHUQMCDSNRDI-AZUAARDMSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-[[(4r)-2,5-dioxoimidazolidin-4-yl]methyl]-4-hydroxybenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)NC[C@H]1NC(=O)NC1=O CNNHUQMCDSNRDI-AZUAARDMSA-N 0.000 claims description 3
- JZLYOOKGQBJXFH-FYZYNONXSA-N 2-[(2s)-3-(6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-methylbenzamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CNC(=O)C1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3CC2)CC1 JZLYOOKGQBJXFH-FYZYNONXSA-N 0.000 claims description 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 3
- 102000009410 Chemokine receptor Human genes 0.000 claims description 3
- 108050000299 Chemokine receptor Proteins 0.000 claims description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 3
- XCUAIINAJCDIPM-XVFCMESISA-N N(4)-hydroxycytidine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=NO)C=C1 XCUAIINAJCDIPM-XVFCMESISA-N 0.000 claims description 3
- PGJMLBBJDCKSIL-VMZNWUEUSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(4s)-4-hydroxy-4-methyl-1,2-oxazolidin-2-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1[C@](C)(O)CON1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 PGJMLBBJDCKSIL-VMZNWUEUSA-N 0.000 claims description 3
- WJPLOPREKWDSCU-SFTDATJTSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1C(=O)N1CC[C@H](O)C1 WJPLOPREKWDSCU-SFTDATJTSA-N 0.000 claims description 3
- YZXXVFCINAUYKV-VXKWHMMOSA-N [2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methylphenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(C)=CC=C1C(=O)N1CC[C@H](O)C1 YZXXVFCINAUYKV-VXKWHMMOSA-N 0.000 claims description 3
- SECKAXOPLXEQFE-QFIPXVFZSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-hydroxypiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCC(O)CC1 SECKAXOPLXEQFE-QFIPXVFZSA-N 0.000 claims description 3
- PGOITOHUWVNKGJ-SFTDATJTSA-N [4-fluoro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(F)=CC=C1C(=O)N1CC[C@H](O)C1 PGOITOHUWVNKGJ-SFTDATJTSA-N 0.000 claims description 3
- NIPKGKYTVFYLQI-HLRBRJAUSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=C(Cl)C=C1C(=O)N1CC[C@H](O)C1 NIPKGKYTVFYLQI-HLRBRJAUSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 claims description 3
- AAGGFBOMSDSILQ-NRFANRHFSA-N n-[2-[(2s)-2-hydroxy-3-(2-methylspiro[indene-1,4'-piperidine]-1'-yl)propoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(C3=CC=CC=C3C=C2C)CC1 AAGGFBOMSDSILQ-NRFANRHFSA-N 0.000 claims description 3
- WWQNMUMGZUECMX-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-fluorophenyl]acetamide Chemical compound CC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(C3=CC(Cl)=CC=C3CO2)CC1 WWQNMUMGZUECMX-IBGZPJMESA-N 0.000 claims description 3
- YYCONHTTWXQXAX-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@@H](O)CN2CCC3(CC2)C2=CC(Cl)=CC=C2CO3)=C1 YYCONHTTWXQXAX-IBGZPJMESA-N 0.000 claims description 3
- UPVHBQNQHFTYOF-IBGZPJMESA-N n-[2-[(2s)-3-(5-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(C3=CC(Cl)=CC=C3CO2)CC1 UPVHBQNQHFTYOF-IBGZPJMESA-N 0.000 claims description 3
- KMXZPXJXPNRBOX-QFIPXVFZSA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-4-hydroxypiperidine-1-carboxamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1NC(=O)N1CCC(O)CC1 KMXZPXJXPNRBOX-QFIPXVFZSA-N 0.000 claims description 3
- DHMMQCJCZXAHQH-IBGZPJMESA-N n-[2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]acetamide Chemical compound CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 DHMMQCJCZXAHQH-IBGZPJMESA-N 0.000 claims description 3
- VHDMPVBNWOJNGA-IBGZPJMESA-N n-[2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 VHDMPVBNWOJNGA-IBGZPJMESA-N 0.000 claims description 3
- GJHXMWQNBXEKLZ-IBGZPJMESA-N n-[2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]acetamide Chemical compound CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 GJHXMWQNBXEKLZ-IBGZPJMESA-N 0.000 claims description 3
- XXVGXVMMAYSGBG-IBGZPJMESA-N n-[2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 XXVGXVMMAYSGBG-IBGZPJMESA-N 0.000 claims description 3
- INLTVBKVCHXVQX-JIDHJSLPSA-N n-[2-[(2s)-3-(6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine]-1'-yl)-2-hydroxy-2-methylpropoxy]-4-hydroxyphenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@](C)(O)CN1CCC2(OC3=CC=C(Cl)C=C3CC2)CC1 INLTVBKVCHXVQX-JIDHJSLPSA-N 0.000 claims description 3
- XMAAYRNVYSWVDO-BDQAORGHSA-N n-[2-[(2s)-3-(6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-fluorophenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3CC2)CC1 XMAAYRNVYSWVDO-BDQAORGHSA-N 0.000 claims description 3
- VPBZMMHNYJIUTK-BDQAORGHSA-N n-[2-[(2s)-3-(6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3CC2)CC1 VPBZMMHNYJIUTK-BDQAORGHSA-N 0.000 claims description 3
- OVABPWVCGOCAMY-FDDCHVKYSA-N n-[2-[(2s)-3-[(2s)-5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine]-1'-yl]-2-hydroxypropoxy]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@@H](O)CN2C[C@]3(CC2)OC2=CC=C(Cl)C=C2C3)=C1 OVABPWVCGOCAMY-FDDCHVKYSA-N 0.000 claims description 3
- QNIANZNXECVERE-PGRDOPGGSA-N n-[2-[(2s)-3-[(2s)-5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine]-1'-yl]-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1C[C@@]2(OC3=CC=C(Cl)C=C3C2)CC1 QNIANZNXECVERE-PGRDOPGGSA-N 0.000 claims description 3
- GJVFBWCTGUSGDD-UHFFFAOYSA-L pentamethonium bromide Chemical compound [Br-].[Br-].C[N+](C)(C)CCCCC[N+](C)(C)C GJVFBWCTGUSGDD-UHFFFAOYSA-L 0.000 claims description 3
- 208000023504 respiratory system disease Diseases 0.000 claims description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- CEOOEPRMLWEACY-UPVQGACJSA-N (2S)-1-[2-[(2S)-3-(5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoyl]-N,N-dimethylpyrrolidine-2-carboxamide Chemical compound CN(C)C(=O)[C@@H]1CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 CEOOEPRMLWEACY-UPVQGACJSA-N 0.000 claims description 2
- ODVQTSRAFAJNJI-DHLKQENFSA-N (2S)-1-[2-[(2S)-3-(6-chlorospiro[1H-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoyl]-N,N-dimethylpyrrolidine-2-carboxamide Chemical compound CN(C)C(=O)[C@@H]1CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 ODVQTSRAFAJNJI-DHLKQENFSA-N 0.000 claims description 2
- HBTRHKSQWBXQBP-IKGOIYPNSA-N (2r)-1-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoyl]pyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC(=O)[C@H]1CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 HBTRHKSQWBXQBP-IKGOIYPNSA-N 0.000 claims description 2
- DFXFLAUBXPDAAJ-GUTACTQSSA-N (3s)-n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-3-hydroxypyrrolidine-1-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1NC(=O)N1CC[C@H](O)C1 DFXFLAUBXPDAAJ-GUTACTQSSA-N 0.000 claims description 2
- LAEXJVXMQKKODQ-GUTACTQSSA-N (3s)-n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxyphenyl]-3-hydroxypyrrolidine-1-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(OC)=CC=C1NC(=O)N1CC[C@H](O)C1 LAEXJVXMQKKODQ-GUTACTQSSA-N 0.000 claims description 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- VCSDBTGLVAYJFD-QHCPKHFHSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxy-2-methylpropoxy]-4-hydroxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(O)C=C1OC[C@@](C)(O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 VCSDBTGLVAYJFD-QHCPKHFHSA-N 0.000 claims description 2
- RDIGAYACKHALNJ-VWLOTQADSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n,n-bis(2-methylpropyl)benzamide Chemical compound CC(C)CN(CC(C)C)C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RDIGAYACKHALNJ-VWLOTQADSA-N 0.000 claims description 2
- NFOAEHJXFCZRNR-FQEVSTJZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-(2-hydroxyethyl)-n-methylbenzamide Chemical compound OCCN(C)C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 NFOAEHJXFCZRNR-FQEVSTJZSA-N 0.000 claims description 2
- GVUCEIVVIYYZPK-NRFANRHFSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-(2-methylpropyl)benzamide Chemical compound CC(C)CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 GVUCEIVVIYYZPK-NRFANRHFSA-N 0.000 claims description 2
- ZWUVZTBEPNKPRA-SANMLTNESA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]-n-(2-methylpropyl)benzamide Chemical compound CC(C)(C)OCCN(CC(C)C)C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 ZWUVZTBEPNKPRA-SANMLTNESA-N 0.000 claims description 2
- RYLHJGPLLZERMW-QFIPXVFZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-pentan-3-ylbenzamide Chemical compound CCC(CC)NC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RYLHJGPLLZERMW-QFIPXVFZSA-N 0.000 claims description 2
- UEKDPFSJCKBKRR-NRFANRHFSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-pyrrolidin-1-ylbenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)NN1CCCC1 UEKDPFSJCKBKRR-NRFANRHFSA-N 0.000 claims description 2
- LLKJRMWVKFEAPB-LMOVPXPDSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxybenzoic acid;hydrochloride Chemical compound Cl.COC1=CC=C(C(O)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1 LLKJRMWVKFEAPB-LMOVPXPDSA-N 0.000 claims description 2
- CCWBFWVRGUHVQK-LMOVPXPDSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-5-fluorobenzoic acid;hydrochloride Chemical compound Cl.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=C(F)C=C1C(O)=O CCWBFWVRGUHVQK-LMOVPXPDSA-N 0.000 claims description 2
- BNRHQUSNKDHPCD-FERBBOLQSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-5-methylbenzoic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC(C)=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 BNRHQUSNKDHPCD-FERBBOLQSA-N 0.000 claims description 2
- RXIIYGHYELPILT-ANYOKISRSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(2,3-dihydroxypropyl)-4-hydroxybenzamide Chemical compound OCC(O)CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RXIIYGHYELPILT-ANYOKISRSA-N 0.000 claims description 2
- VCOGITWISLZFKJ-KRWDZBQOSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(2h-tetrazol-5-yl)benzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1C(=O)NC1=NN=NN1 VCOGITWISLZFKJ-KRWDZBQOSA-N 0.000 claims description 2
- OTLFHECCVWWEEX-DEOSSOPVSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(cyclopropylmethyl)-4-hydroxy-n-propylbenzamide Chemical compound C=1C=C(O)C=C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)C=1C(=O)N(CCC)CC1CC1 OTLFHECCVWWEEX-DEOSSOPVSA-N 0.000 claims description 2
- RLRCRKXUWIIQRX-NRFANRHFSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(cyclopropylmethyl)-4-hydroxybenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)NCC1CC1 RLRCRKXUWIIQRX-NRFANRHFSA-N 0.000 claims description 2
- CRLDAEJBDUQUJM-CUDBROORSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-[[(1s,4r,5s)-6,6-dimethyl-4-bicyclo[3.1.1]heptanyl]methyl]-4-hydroxybenzamide Chemical compound C1C2=CC(Cl)=CC=C2OC1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)NC[C@H](CC1)[C@@H]2C[C@H]1C2(C)C CRLDAEJBDUQUJM-CUDBROORSA-N 0.000 claims description 2
- TVYZQJORHXHWDJ-QFIPXVFZSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopentyl-4-hydroxybenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)NC1CCCC1 TVYZQJORHXHWDJ-QFIPXVFZSA-N 0.000 claims description 2
- VBXAPQDURMBUSH-VWLOTQADSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n,n-bis(2-methylpropyl)benzamide Chemical compound CC(C)CN(CC(C)C)C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 VBXAPQDURMBUSH-VWLOTQADSA-N 0.000 claims description 2
- SSGQIBYNOQYEFV-FQEVSTJZSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-(2-hydroxyethyl)-n-methylbenzamide Chemical compound OCCN(C)C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 SSGQIBYNOQYEFV-FQEVSTJZSA-N 0.000 claims description 2
- RCFQWYDZJNZFBG-NRFANRHFSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-(2-methylpropyl)benzamide Chemical compound CC(C)CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 RCFQWYDZJNZFBG-NRFANRHFSA-N 0.000 claims description 2
- PRBZGZHHESUZFN-SANMLTNESA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]-n-(2-methylpropyl)benzamide Chemical compound CC(C)(C)OCCN(CC(C)C)C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 PRBZGZHHESUZFN-SANMLTNESA-N 0.000 claims description 2
- HRHHAHVWFIWZLA-QFIPXVFZSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-pentan-3-ylbenzamide Chemical compound CCC(CC)NC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 HRHHAHVWFIWZLA-QFIPXVFZSA-N 0.000 claims description 2
- SVLMNOWJZWMRGE-NRFANRHFSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-pyrrolidin-1-ylbenzamide Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)NN1CCCC1 SVLMNOWJZWMRGE-NRFANRHFSA-N 0.000 claims description 2
- XOMSMZBBNXIPRO-ANYOKISRSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(2,3-dihydroxypropyl)-4-hydroxybenzamide Chemical compound OCC(O)CNC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 XOMSMZBBNXIPRO-ANYOKISRSA-N 0.000 claims description 2
- KODHAPJXTQZVPA-DEOSSOPVSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(cyclopropylmethyl)-4-hydroxy-n-propylbenzamide Chemical compound C=1C=C(O)C=C(OC[C@@H](O)CN2CCC3(CC2)C2=CC=C(Cl)C=C2CO3)C=1C(=O)N(CCC)CC1CC1 KODHAPJXTQZVPA-DEOSSOPVSA-N 0.000 claims description 2
- QIGZIQWTJSCCQT-NRFANRHFSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(cyclopropylmethyl)-4-hydroxybenzamide Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)NCC1CC1 QIGZIQWTJSCCQT-NRFANRHFSA-N 0.000 claims description 2
- XUWVHNKZZHTFGV-QFIPXVFZSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-cyclopentyl-4-hydroxybenzamide Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)NC1CCCC1 XUWVHNKZZHTFGV-QFIPXVFZSA-N 0.000 claims description 2
- YUSQCZIJNLLMDT-FYZYNONXSA-N 4-acetamido-3-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]benzoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(C(O)=O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 YUSQCZIJNLLMDT-FYZYNONXSA-N 0.000 claims description 2
- NTQKQYRHEDCNDP-KRWDZBQOSA-N 4-fluoro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]benzoic acid Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(F)=CC=C1C(O)=O NTQKQYRHEDCNDP-KRWDZBQOSA-N 0.000 claims description 2
- HLWPIHJEKHHTIK-LMOVPXPDSA-N 5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]benzoic acid;hydrochloride Chemical compound Cl.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=C(Cl)C=C1C(O)=O HLWPIHJEKHHTIK-LMOVPXPDSA-N 0.000 claims description 2
- PYPNDMXTZSMTMD-KRWDZBQOSA-N [2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]phenyl]urea Chemical compound NC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1 PYPNDMXTZSMTMD-KRWDZBQOSA-N 0.000 claims description 2
- OMVDCVXVNGBZNA-VWLOTQADSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(1,3-dihydroisoindol-2-yl)methanone Chemical compound C1C2=CC(Cl)=CC=C2OC1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)N1CC2=CC=CC=C2C1 OMVDCVXVNGBZNA-VWLOTQADSA-N 0.000 claims description 2
- YYZPREJNSYQLDX-SANMLTNESA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(3,4-dihydro-1h-isoquinolin-2-yl)methanone Chemical compound C1C2=CC(Cl)=CC=C2OC1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)N1CC2=CC=CC=C2CC1 YYZPREJNSYQLDX-SANMLTNESA-N 0.000 claims description 2
- UELDKHWSTGLYTB-KEKNWZKVSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(3-hydroxypiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCCC(O)C1 UELDKHWSTGLYTB-KEKNWZKVSA-N 0.000 claims description 2
- ZUPYIOOKETVEMR-NRFANRHFSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4,4-difluoropiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCC(F)(F)CC1 ZUPYIOOKETVEMR-NRFANRHFSA-N 0.000 claims description 2
- FFVLPMQXUGWQFR-QFIPXVFZSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-fluoropiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCC(F)CC1 FFVLPMQXUGWQFR-QFIPXVFZSA-N 0.000 claims description 2
- MUHURPCIRWHMHY-MHZLTWQESA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-hydroxy-4-phenylpiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N(CC1)CCC1(O)C1=CC=CC=C1 MUHURPCIRWHMHY-MHZLTWQESA-N 0.000 claims description 2
- HZQMSPWSILEWET-NDEPHWFRSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-phenylpiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N(CC1)CCC1C1=CC=CC=C1 HZQMSPWSILEWET-NDEPHWFRSA-N 0.000 claims description 2
- HMIUKGJKCUMYLE-LBPAWUGGSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC[C@H]1CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 HMIUKGJKCUMYLE-LBPAWUGGSA-N 0.000 claims description 2
- HMIUKGJKCUMYLE-DTRWSJPISA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC[C@@H]1CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 HMIUKGJKCUMYLE-DTRWSJPISA-N 0.000 claims description 2
- QRISUYWARARGGC-GGAORHGYSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-(dimethylamino)pyrrolidin-1-yl]methanone Chemical compound C1[C@H](N(C)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 QRISUYWARARGGC-GGAORHGYSA-N 0.000 claims description 2
- UELDKHWSTGLYTB-YADHBBJMSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-hydroxypiperidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCC[C@@H](O)C1 UELDKHWSTGLYTB-YADHBBJMSA-N 0.000 claims description 2
- NNGVIXWUXNGOKZ-VROPFNGYSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-methoxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1[C@@H](OC)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 NNGVIXWUXNGOKZ-VROPFNGYSA-N 0.000 claims description 2
- PGJMLBBJDCKSIL-XWGBWKJCSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(4r)-4-hydroxy-4-methyl-1,2-oxazolidin-2-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1[C@@](C)(O)CON1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 PGJMLBBJDCKSIL-XWGBWKJCSA-N 0.000 claims description 2
- DKQCNVLJRYKDMR-YANBTOMASA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[2-(hydroxymethyl)piperidin-1-yl]methanone Chemical compound OCC1CCCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 DKQCNVLJRYKDMR-YANBTOMASA-N 0.000 claims description 2
- AMAREIOXYAIQNI-BVHINDKJSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[3-(hydroxymethyl)piperidin-1-yl]methanone Chemical compound C1C(CO)CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 AMAREIOXYAIQNI-BVHINDKJSA-N 0.000 claims description 2
- ODMPQZQBYDUVEW-KJIPLLCSSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[3-(hydroxymethyl)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1C(CO)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 ODMPQZQBYDUVEW-KJIPLLCSSA-N 0.000 claims description 2
- NAOPSNUTYGOLJD-QHCPKHFHSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone Chemical compound C1CN(CCO)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 NAOPSNUTYGOLJD-QHCPKHFHSA-N 0.000 claims description 2
- GVEGKXGPFHPFQK-NRFANRHFSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-thiomorpholin-4-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCSCC1 GVEGKXGPFHPFQK-NRFANRHFSA-N 0.000 claims description 2
- KWZOWMURBABLIZ-GUTACTQSSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxyphenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(OC)=CC=C1C(=O)N1CC[C@H](O)C1 KWZOWMURBABLIZ-GUTACTQSSA-N 0.000 claims description 2
- HKKKHBWMPJEMLM-GUTACTQSSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-5-fluorophenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=C(F)C=C1C(=O)N1CC[C@H](O)C1 HKKKHBWMPJEMLM-GUTACTQSSA-N 0.000 claims description 2
- RUHUNNJGRLKERA-VROPFNGYSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-5-methylphenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C(C)=CC=C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)C=1C(=O)N1CC[C@H](O)C1 RUHUNNJGRLKERA-VROPFNGYSA-N 0.000 claims description 2
- UTQRUZBUCQFZJL-NRFANRHFSA-N [2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-pyrrolidin-1-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CCCC1 UTQRUZBUCQFZJL-NRFANRHFSA-N 0.000 claims description 2
- BJGVEBIHODKJJK-SFTDATJTSA-N [2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC=CC=C1C(=O)N1CC[C@H](O)C1 BJGVEBIHODKJJK-SFTDATJTSA-N 0.000 claims description 2
- NJRFACAMIZOMLR-KRWDZBQOSA-N [2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]urea Chemical compound NC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 NJRFACAMIZOMLR-KRWDZBQOSA-N 0.000 claims description 2
- WAJLJQOMAWNTSB-VWLOTQADSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(1,3-dihydroisoindol-2-yl)methanone Chemical compound O1CC2=CC(Cl)=CC=C2C1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)N1CC2=CC=CC=C2C1 WAJLJQOMAWNTSB-VWLOTQADSA-N 0.000 claims description 2
- HKADCRYRMJZRSZ-SANMLTNESA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(3,4-dihydro-1h-isoquinolin-2-yl)methanone Chemical compound O1CC2=CC(Cl)=CC=C2C1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)N1CC2=CC=CC=C2CC1 HKADCRYRMJZRSZ-SANMLTNESA-N 0.000 claims description 2
- FEBMTXUZLTURQN-KEKNWZKVSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(3-hydroxypiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCCC(O)C1 FEBMTXUZLTURQN-KEKNWZKVSA-N 0.000 claims description 2
- ZOTPVVUOEQXZQR-NRFANRHFSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4,4-difluoropiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCC(F)(F)CC1 ZOTPVVUOEQXZQR-NRFANRHFSA-N 0.000 claims description 2
- XOZINJXXXIBCFL-MHZLTWQESA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-hydroxy-4-phenylpiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N(CC1)CCC1(O)C1=CC=CC=C1 XOZINJXXXIBCFL-MHZLTWQESA-N 0.000 claims description 2
- QHVZWEDCAHBNON-NDEPHWFRSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-phenylpiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N(CC1)CCC1C1=CC=CC=C1 QHVZWEDCAHBNON-NDEPHWFRSA-N 0.000 claims description 2
- VDMQXCPFFUGGQA-LBHUVFDKSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(2r)-2-[hydroxy(diphenyl)methyl]pyrrolidin-1-yl]methanone Chemical compound C=1C=CC=CC=1C(O)([C@H]1CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)C1=CC=CC=C1 VDMQXCPFFUGGQA-LBHUVFDKSA-N 0.000 claims description 2
- FEBMTXUZLTURQN-YADHBBJMSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-hydroxypiperidin-1-yl]methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCC[C@@H](O)C1 FEBMTXUZLTURQN-YADHBBJMSA-N 0.000 claims description 2
- XZYXYAOKBGPIKP-YANBTOMASA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[2-(hydroxymethyl)piperidin-1-yl]methanone Chemical compound OCC1CCCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 XZYXYAOKBGPIKP-YANBTOMASA-N 0.000 claims description 2
- KZCJJXLIQYDWDN-YANBTOMASA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[3-(dimethylamino)pyrrolidin-1-yl]methanone Chemical compound C1C(N(C)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 KZCJJXLIQYDWDN-YANBTOMASA-N 0.000 claims description 2
- LRFHMVSWSKGFBR-BVHINDKJSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[3-(hydroxymethyl)piperidin-1-yl]methanone Chemical compound C1C(CO)CCCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 LRFHMVSWSKGFBR-BVHINDKJSA-N 0.000 claims description 2
- RCXIBASKXDDXFQ-QHCPKHFHSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone Chemical compound C1CN(CCO)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 RCXIBASKXDDXFQ-QHCPKHFHSA-N 0.000 claims description 2
- YILOFKUITMIAIL-QHCPKHFHSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[4-(hydroxymethyl)piperidin-1-yl]methanone Chemical compound C1CC(CO)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 YILOFKUITMIAIL-QHCPKHFHSA-N 0.000 claims description 2
- SVAKNXYGZOGSMD-NRFANRHFSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-pyrrolidin-1-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCCC1 SVAKNXYGZOGSMD-NRFANRHFSA-N 0.000 claims description 2
- WYILRBZJWSPTQN-NRFANRHFSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-thiomorpholin-4-ylmethanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCSCC1 WYILRBZJWSPTQN-NRFANRHFSA-N 0.000 claims description 2
- RPZQUYZMUVHLQL-MHZLTWQESA-N [4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]methanone Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RPZQUYZMUVHLQL-MHZLTWQESA-N 0.000 claims description 2
- KOLDNYIEOCNCDU-MHZLTWQESA-N [4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-[2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N(CC1)CCC1(O)C1=CC=C(Cl)C=C1 KOLDNYIEOCNCDU-MHZLTWQESA-N 0.000 claims description 2
- HJXVYHOZYUDMBT-KRWDZBQOSA-N [4-fluoro-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]phenyl]urea Chemical compound NC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1 HJXVYHOZYUDMBT-KRWDZBQOSA-N 0.000 claims description 2
- HDXYWFYXIUIVBI-KRWDZBQOSA-N [4-fluoro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]urea Chemical compound NC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 HDXYWFYXIUIVBI-KRWDZBQOSA-N 0.000 claims description 2
- OGDJWXFNPORUAE-GUTACTQSSA-N [4-hydroxy-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1)OC1=CC(O)=CC=C1C(=O)N1CC[C@H](O)C1 OGDJWXFNPORUAE-GUTACTQSSA-N 0.000 claims description 2
- BBYOZLNZZSOUQC-RTWAWAEBSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-(dimethylamino)pyrrolidin-1-yl]methanone Chemical compound C1[C@H](N(C)C)CCN1C(=O)C1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 BBYOZLNZZSOUQC-RTWAWAEBSA-N 0.000 claims description 2
- RWUKCNZXDKRFTK-XLCHORMMSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-(hydroxymethyl)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1[C@H](CO)CCN1C(=O)C1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RWUKCNZXDKRFTK-XLCHORMMSA-N 0.000 claims description 2
- RWUKCNZXDKRFTK-ZHXLSBKVSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-(hydroxymethyl)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1[C@@H](CO)CCN1C(=O)C1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RWUKCNZXDKRFTK-ZHXLSBKVSA-N 0.000 claims description 2
- ASTDWBKRDUDRMN-RSAXXLAASA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]urea;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC(=O)NC1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 ASTDWBKRDUDRMN-RSAXXLAASA-N 0.000 claims description 2
- HLVXFRMNXWUTNW-GUTACTQSSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=C(Cl)C=C1C(=O)N1CC[C@H](O)C1 HLVXFRMNXWUTNW-GUTACTQSSA-N 0.000 claims description 2
- LICONORQJYNQTD-KRWDZBQOSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]urea Chemical compound NC(=O)NC1=CC(Cl)=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 LICONORQJYNQTD-KRWDZBQOSA-N 0.000 claims description 2
- MWRPZAMZKVBLSZ-FYZYNONXSA-N [5-chloro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-pyrrolidin-1-ylmethanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(O)=C(Cl)C=C1C(=O)N1CCCC1 MWRPZAMZKVBLSZ-FYZYNONXSA-N 0.000 claims description 2
- GNSJATKVTHHPKL-RSAXXLAASA-N [5-chloro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]urea;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC(=O)NC1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 GNSJATKVTHHPKL-RSAXXLAASA-N 0.000 claims description 2
- HYMUOUCFHICCFE-KRWDZBQOSA-N [5-chloro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]urea Chemical compound NC(=O)NC1=CC(Cl)=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 HYMUOUCFHICCFE-KRWDZBQOSA-N 0.000 claims description 2
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- AZACZONDDWDIIG-GIWBLDEGSA-N methyl (2s,4r)-1-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoyl]-4-hydroxypyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1C[C@@H](O)CN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 AZACZONDDWDIIG-GIWBLDEGSA-N 0.000 claims description 2
- CADAUXUBZGVJBB-DPLHUUCSSA-N methyl (2s,4r)-1-[2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoyl]-4-hydroxypyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1C[C@@H](O)CN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(C3=CC=C(Cl)C=C3CO2)CC1 CADAUXUBZGVJBB-DPLHUUCSSA-N 0.000 claims description 2
- 201000006417 multiple sclerosis Diseases 0.000 claims description 2
- ZUQZJIAQNHXNEN-JJKABECESA-N n-[(1s,4r)-3-bicyclo[2.2.1]heptanyl]-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzamide Chemical compound C1C2=CC(Cl)=CC=C2OC1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)NC1[C@@H](C2)CC[C@@H]2C1 ZUQZJIAQNHXNEN-JJKABECESA-N 0.000 claims description 2
- YQVPJDWFLXSVQZ-DRWWIJIRSA-N n-[(1s,4r)-3-bicyclo[2.2.1]heptanyl]-2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzamide Chemical compound O1CC2=CC(Cl)=CC=C2C1(CC1)CCN1C[C@H](O)COC1=CC(O)=CC=C1C(=O)NC1[C@@H](C2)CC[C@@H]2C1 YQVPJDWFLXSVQZ-DRWWIJIRSA-N 0.000 claims description 2
- LZOWWFLUDKRHIE-LJQANCHMSA-N n-[2-[(2r)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@H](O)CN2CCC3(OC4=CC=C(F)C=C4C3)CC2)=C1 LZOWWFLUDKRHIE-LJQANCHMSA-N 0.000 claims description 2
- MVKFMYBCYYFJGY-NWLLBJEDSA-N n-[2-[(2s)-3-(5-chloro-3'-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]acetamide Chemical compound CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CC(F)C2(OC3=CC=C(Cl)C=C3C2)CC1 MVKFMYBCYYFJGY-NWLLBJEDSA-N 0.000 claims description 2
- QGQYIGBURHJEID-BOXHHOBZSA-N n-[2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]pyrrolidine-1-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1NC(=O)N1CCCC1 QGQYIGBURHJEID-BOXHHOBZSA-N 0.000 claims description 2
- RMHUVJLXJRIZKP-BDQAORGHSA-N n-[2-[(2s)-3-(6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3CC2)CC1 RMHUVJLXJRIZKP-BDQAORGHSA-N 0.000 claims description 2
- MQFZZRAWHHBMEC-IBGZPJMESA-N n-[4-fluoro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(F)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1 MQFZZRAWHHBMEC-IBGZPJMESA-N 0.000 claims description 2
- MSJGDTWIBJNLQZ-BDQAORGHSA-N n-[4-hydroxy-2-[(2s)-2-hydroxy-3-(5-methylspiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)propoxy]phenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(C)C=C3C2)CC1 MSJGDTWIBJNLQZ-BDQAORGHSA-N 0.000 claims description 2
- GKWGXHKSACKVKJ-FYZYNONXSA-N n-[4-hydroxy-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]phenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1 GKWGXHKSACKVKJ-FYZYNONXSA-N 0.000 claims description 2
- KNIVPIMULMNHOI-FERBBOLQSA-N n-[5-chloro-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]-4-methoxyphenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(Cl)C(OC)=CC(OC[C@@H](O)CN2CCC3(OC4=CC=CC=C4C3)CC2)=C1NC(C)=O KNIVPIMULMNHOI-FERBBOLQSA-N 0.000 claims description 2
- IZKIVTJMZWVWBB-BOXHHOBZSA-N n-[5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]benzamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=C(Cl)C=C1NC(=O)C1=CC=CC=C1 IZKIVTJMZWVWBB-BOXHHOBZSA-N 0.000 claims description 2
- XGPQQSZIDNPEDY-BOXHHOBZSA-N n-[5-chloro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]benzamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(O)=C(Cl)C=C1NC(=O)C1=CC=CC=C1 XGPQQSZIDNPEDY-BOXHHOBZSA-N 0.000 claims description 2
- XBDJPCQVXTWCKF-UHFFFAOYSA-N n-[5-chloro-2-[3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]cyclopentanecarboxamide Chemical compound C1CC2(OC3=CC=C(Cl)C=C3C2)CCN1CC(O)COC1=CC(O)=C(Cl)C=C1NC(=O)C1CCCC1 XBDJPCQVXTWCKF-UHFFFAOYSA-N 0.000 claims description 2
- BZJHGZLITVDVBJ-UHFFFAOYSA-N n-[5-chloro-2-[3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]cyclopentanecarboxamide Chemical compound C1CC2(OC3=CC=C(F)C=C3C2)CCN1CC(O)COC1=CC(O)=C(Cl)C=C1NC(=O)C1CCCC1 BZJHGZLITVDVBJ-UHFFFAOYSA-N 0.000 claims description 2
- WHNBVDZDMQZKMM-UHFFFAOYSA-N n-[5-chloro-4-hydroxy-2-(2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy)phenyl]cyclopentanecarboxamide Chemical compound C1CC2(OC3=CC=CC=C3C2)CCN1CC(O)COC1=CC(O)=C(Cl)C=C1NC(=O)C1CCCC1 WHNBVDZDMQZKMM-UHFFFAOYSA-N 0.000 claims description 2
- KWJBCNQSGUHQCK-LMOVPXPDSA-N n-[5-chloro-4-hydroxy-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]phenyl]acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(=O)NC1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1 KWJBCNQSGUHQCK-LMOVPXPDSA-N 0.000 claims description 2
- MKWUVQYITYWIHJ-FQEVSTJZSA-N n-tert-butyl-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzamide Chemical compound CC(C)(C)NC(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 MKWUVQYITYWIHJ-FQEVSTJZSA-N 0.000 claims description 2
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- HMOAOQLOMYBMPQ-FQEVSTJZSA-N N-[2-[(2S)-3-(6-fluorospiro[1H-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropyl]phenyl]acetamide Chemical compound C(C)(=O)NC1=C(C=CC=C1)C[C@@H](CN1CCC2(CC1)OCC1=C2C=CC(=C1)F)O HMOAOQLOMYBMPQ-FQEVSTJZSA-N 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 444
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 393
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 374
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 216
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 215
- 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 212
- 238000005160 1H NMR spectroscopy Methods 0.000 description 206
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 151
- 239000011541 reaction mixture Substances 0.000 description 148
- 239000000243 solution Substances 0.000 description 141
- 239000000203 mixture Substances 0.000 description 139
- 239000000741 silica gel Substances 0.000 description 138
- 229910002027 silica gel Inorganic materials 0.000 description 138
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 138
- 235000019439 ethyl acetate Nutrition 0.000 description 127
- 238000003818 flash chromatography Methods 0.000 description 125
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 120
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 101
- 239000003039 volatile agent Substances 0.000 description 101
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 99
- 239000012044 organic layer Substances 0.000 description 90
- 239000011734 sodium Substances 0.000 description 89
- 238000003756 stirring Methods 0.000 description 75
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 74
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 69
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 63
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 54
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 52
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 51
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 38
- 239000000908 ammonium hydroxide Substances 0.000 description 38
- 239000007787 solid Substances 0.000 description 38
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 34
- 238000010992 reflux Methods 0.000 description 33
- 239000002904 solvent Substances 0.000 description 32
- 229910052938 sodium sulfate Inorganic materials 0.000 description 31
- 235000011152 sodium sulphate Nutrition 0.000 description 31
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 30
- 238000004128 high performance liquid chromatography Methods 0.000 description 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 23
- 239000000725 suspension Substances 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 22
- 239000003208 petroleum Substances 0.000 description 22
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 20
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 20
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 19
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 17
- 239000010410 layer Substances 0.000 description 17
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 16
- 238000000746 purification Methods 0.000 description 16
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 14
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 14
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 14
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 13
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 13
- 229910000024 caesium carbonate Inorganic materials 0.000 description 13
- 229910052740 iodine Inorganic materials 0.000 description 13
- 239000011630 iodine Substances 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- JHHZLHWJQPUNKB-BYPYZUCNSA-N (3s)-pyrrolidin-3-ol Chemical compound O[C@H]1CCNC1 JHHZLHWJQPUNKB-BYPYZUCNSA-N 0.000 description 12
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 12
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 12
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 12
- 229910052794 bromium Inorganic materials 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 11
- 239000012074 organic phase Substances 0.000 description 11
- 206010039083 rhinitis Diseases 0.000 description 11
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
- AIHIHVZYAAMDPM-QMMMGPOBSA-N [(2s)-oxiran-2-yl]methyl 3-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=CC=CC(S(=O)(=O)OC[C@H]2OC2)=C1 AIHIHVZYAAMDPM-QMMMGPOBSA-N 0.000 description 10
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 10
- JXHYCCGOZUGBFD-UHFFFAOYSA-N benzoic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1 JXHYCCGOZUGBFD-UHFFFAOYSA-N 0.000 description 10
- 239000012267 brine Substances 0.000 description 10
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 10
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 10
- BNCMXVQENIJAEW-UHFFFAOYSA-N 5-(trifluoromethyl)spiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(C(F)(F)F)=CC=C2OC21CCNCC2 BNCMXVQENIJAEW-UHFFFAOYSA-N 0.000 description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 9
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 9
- 125000006606 n-butoxy group Chemical group 0.000 description 9
- 125000003386 piperidinyl group Chemical group 0.000 description 9
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 9
- 229910000104 sodium hydride Inorganic materials 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 239000013058 crude material Substances 0.000 description 8
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 8
- SENIMHNFLVMDJV-VIFPVBQESA-N n-[2-[[(2s)-oxiran-2-yl]methoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC=C1OC[C@H]1OC1 SENIMHNFLVMDJV-VIFPVBQESA-N 0.000 description 8
- 238000002953 preparative HPLC Methods 0.000 description 8
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 8
- SJZKULRDWHPHGG-UHFFFAOYSA-N 1-benzylpiperidin-4-one Chemical compound C1CC(=O)CCN1CC1=CC=CC=C1 SJZKULRDWHPHGG-UHFFFAOYSA-N 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 7
- HDTDGVNYXDYKSO-JTQLQIEISA-N [(2s)-2-methyloxiran-2-yl]methyl 3-nitrobenzenesulfonate Chemical compound C=1C=CC([N+]([O-])=O)=CC=1S(=O)(=O)OC[C@]1(C)CO1 HDTDGVNYXDYKSO-JTQLQIEISA-N 0.000 description 7
- 238000004108 freeze drying Methods 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- ZELCJNKQCKIECO-UHFFFAOYSA-N spiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC=CC=C2OC11CCNCC1 ZELCJNKQCKIECO-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 description 6
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 6
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 125000003831 tetrazolyl group Chemical group 0.000 description 6
- BDYDBRINEAMBRZ-UHFFFAOYSA-N 5-chlorospiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(Cl)=CC=C2OC21CCNCC2 BDYDBRINEAMBRZ-UHFFFAOYSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 125000000068 chlorophenyl group Chemical group 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 125000002541 furyl group Chemical group 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 5
- 125000004076 pyridyl group Chemical group 0.000 description 5
- 125000000168 pyrrolyl group Chemical group 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- BYOIMOJOKVUNTP-UHFFFAOYSA-N spiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C12=CC=CC=C2COC21CCNCC2 BYOIMOJOKVUNTP-UHFFFAOYSA-N 0.000 description 5
- 125000001544 thienyl group Chemical group 0.000 description 5
- RSQAPOCNEFFZOK-UHFFFAOYSA-N 1'-benzyl-5-fluorospiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(F)=CC=C2OC1(CC1)CCN1CC1=CC=CC=C1 RSQAPOCNEFFZOK-UHFFFAOYSA-N 0.000 description 4
- DYQAWFUHUWWRIX-UHFFFAOYSA-N 1-benzyl-4-[(2,5-difluorophenyl)methyl]piperidin-4-ol Chemical compound C1CN(CC=2C=CC=CC=2)CCC1(O)CC1=CC(F)=CC=C1F DYQAWFUHUWWRIX-UHFFFAOYSA-N 0.000 description 4
- LPYKWIQXGJBFHS-UHFFFAOYSA-N 2-(4-hydroxy-1,2-oxazolidine-2-carbonyl)benzoic acid Chemical compound C1C(O)CON1C(=O)C1=CC=CC=C1C(O)=O LPYKWIQXGJBFHS-UHFFFAOYSA-N 0.000 description 4
- ONWGSWNHQZYCFK-UHFFFAOYSA-N 2-(bromomethyl)-1,4-difluorobenzene Chemical compound FC1=CC=C(F)C(CBr)=C1 ONWGSWNHQZYCFK-UHFFFAOYSA-N 0.000 description 4
- NKQVDPDIJRAJLL-UHFFFAOYSA-N 6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine] Chemical compound C1CC2=CC(Cl)=CC=C2OC21CCNCC2 NKQVDPDIJRAJLL-UHFFFAOYSA-N 0.000 description 4
- 208000030507 AIDS Diseases 0.000 description 4
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 description 4
- 102000019034 Chemokines Human genes 0.000 description 4
- 108010012236 Chemokines Proteins 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- CTWPAWPBBVYSIH-KMDCRFISSA-N [5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-(dimethylamino)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1[C@H](N(C)C)CCN1C(=O)C1=CC(Cl)=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 CTWPAWPBBVYSIH-KMDCRFISSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 4
- 125000001041 indolyl group Chemical group 0.000 description 4
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 4
- IIFCLXHRIYTHPV-UHFFFAOYSA-N methyl 2,4-dihydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C=C1O IIFCLXHRIYTHPV-UHFFFAOYSA-N 0.000 description 4
- IANXOBHKQWFRAH-UHFFFAOYSA-N methyl 2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1OCC1=CC=C(OC)C=C1 IANXOBHKQWFRAH-UHFFFAOYSA-N 0.000 description 4
- 229940095102 methyl benzoate Drugs 0.000 description 4
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 4
- 125000002757 morpholinyl group Chemical group 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 4
- CBAUIWUNQWUPDH-UHFFFAOYSA-N 1'-benzyl-5-chlorospiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C12=CC(Cl)=CC=C2COC1(CC1)CCN1CC1=CC=CC=C1 CBAUIWUNQWUPDH-UHFFFAOYSA-N 0.000 description 3
- MLODJXIQFZSFIC-UHFFFAOYSA-N 1'-benzyl-6-chlorospiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C=1C(Cl)=CC=C2C=1COC2(CC1)CCN1CC1=CC=CC=C1 MLODJXIQFZSFIC-UHFFFAOYSA-N 0.000 description 3
- DJXBUSVMEONVRS-UHFFFAOYSA-N 2-(bromomethyl)-4-chloro-1-fluorobenzene Chemical compound FC1=CC=C(Cl)C=C1CBr DJXBUSVMEONVRS-UHFFFAOYSA-N 0.000 description 3
- YEWLSPWSDMWYAG-FERBBOLQSA-N 2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-methylbenzoic acid;hydrochloride Chemical compound Cl.CC1=CC=C(C(O)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(F)C=C4C3)CC2)=C1 YEWLSPWSDMWYAG-FERBBOLQSA-N 0.000 description 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 3
- RZKJWYDRDBVDJJ-UHFFFAOYSA-N 2-methyl-1,3-benzoxazol-6-ol Chemical compound C1=C(O)C=C2OC(C)=NC2=C1 RZKJWYDRDBVDJJ-UHFFFAOYSA-N 0.000 description 3
- NRBZLVPUYKSSHX-UHFFFAOYSA-N 5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine] Chemical compound C1C2=CC(Cl)=CC=C2OC21CCNC2 NRBZLVPUYKSSHX-UHFFFAOYSA-N 0.000 description 3
- QAJSCZSRUBMWMH-UHFFFAOYSA-N 5-fluorospiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(F)=CC=C2OC21CCNCC2 QAJSCZSRUBMWMH-UHFFFAOYSA-N 0.000 description 3
- GTFGKCXKGCAGLO-UHFFFAOYSA-N 5-methylspiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(C)=CC=C2OC21CCNCC2 GTFGKCXKGCAGLO-UHFFFAOYSA-N 0.000 description 3
- QAEQUICBVZIZRS-UHFFFAOYSA-N 6-fluorospiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C=1C(F)=CC=C2C=1COC21CCNCC1 QAEQUICBVZIZRS-UHFFFAOYSA-N 0.000 description 3
- ONMOULMPIIOVTQ-UHFFFAOYSA-N 98-47-5 Chemical compound OS(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 ONMOULMPIIOVTQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- TZMNUZRJZAIMTD-NSHDSACASA-N [4-acetamido-3-[[(2s)-oxiran-2-yl]methoxy]phenyl] acetate Chemical compound CC(=O)NC1=CC=C(OC(C)=O)C=C1OC[C@H]1OC1 TZMNUZRJZAIMTD-NSHDSACASA-N 0.000 description 3
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 3
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical class II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- 125000000842 isoxazolyl group Chemical group 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 3
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- TXMMVGGBWVGVIU-JTQLQIEISA-N n-cyclopropyl-2-[[(2s)-oxiran-2-yl]methoxy]benzamide Chemical compound C=1C=CC=C(OC[C@H]2OC2)C=1C(=O)NC1CC1 TXMMVGGBWVGVIU-JTQLQIEISA-N 0.000 description 3
- 125000006252 n-propylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 3
- 229940049953 phenylacetate Drugs 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000003226 pyrazolyl group Chemical group 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 125000001113 thiadiazolyl group Chemical group 0.000 description 3
- 125000001984 thiazolidinyl group Chemical group 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 3
- 125000001425 triazolyl group Chemical group 0.000 description 3
- LLCWGQYEQKYRDO-AENDTGMFSA-N (4r)-1,2-oxazolidin-4-ol;hydrochloride Chemical compound Cl.O[C@@H]1CNOC1 LLCWGQYEQKYRDO-AENDTGMFSA-N 0.000 description 2
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 description 2
- ICCVFSKTWHYOMI-UHFFFAOYSA-N 1'-benzyl-5-(trifluoromethyl)spiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(C(F)(F)F)=CC=C2OC1(CC1)CCN1CC1=CC=CC=C1 ICCVFSKTWHYOMI-UHFFFAOYSA-N 0.000 description 2
- FSDLNPSOIALTPQ-UHFFFAOYSA-N 1'-benzyl-5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine] Chemical compound C1C2=CC(Cl)=CC=C2OC1(C1)CCN1CC1=CC=CC=C1 FSDLNPSOIALTPQ-UHFFFAOYSA-N 0.000 description 2
- DCLHZJZXVCDJTL-UHFFFAOYSA-N 1'-benzyl-5-methylspiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound C1C2=CC(C)=CC=C2OC1(CC1)CCN1CC1=CC=CC=C1 DCLHZJZXVCDJTL-UHFFFAOYSA-N 0.000 description 2
- STWVASSSAJNLSD-UHFFFAOYSA-N 1'-benzyl-6-fluorospiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C=1C(F)=CC=C2C=1COC2(CC1)CCN1CC1=CC=CC=C1 STWVASSSAJNLSD-UHFFFAOYSA-N 0.000 description 2
- WECGXQVPFXUYMV-UHFFFAOYSA-N 1'-benzyl-6-fluorospiro[2-benzofuran-3,4'-piperidine]-1-one Chemical compound C=1C(F)=CC=C2C=1C(=O)OC2(CC1)CCN1CC1=CC=CC=C1 WECGXQVPFXUYMV-UHFFFAOYSA-N 0.000 description 2
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 2
- XYUPPXPJWYLXSW-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=C[CH]C2=C=COC2=C1 XYUPPXPJWYLXSW-UHFFFAOYSA-N 0.000 description 2
- LFLOVZOBPGPPJM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;3-(trifluoromethyl)pyrrolidine Chemical compound OC(=O)C(F)(F)F.FC(F)(F)C1CCNC1 LFLOVZOBPGPPJM-UHFFFAOYSA-N 0.000 description 2
- BYRMZRWUEAESEZ-UHFFFAOYSA-N 2-(bromomethyl)-1-fluoro-4-(trifluoromethyl)benzene Chemical compound FC1=CC=C(C(F)(F)F)C=C1CBr BYRMZRWUEAESEZ-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- GDSGNBQBVUGRPS-BQAIUKQQSA-N 2-[(2S)-3-(6-chlorospiro[1H-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]benzoic acid hydrochloride Chemical compound COC1=CC=C(C=C1)COC2=CC(=C(C=C2)C(=O)O)OC[C@H](CN3CCC4(CC3)C5=C(CO4)C=C(C=C5)Cl)O.Cl GDSGNBQBVUGRPS-BQAIUKQQSA-N 0.000 description 2
- MKAAKNSKKFKNRJ-LBPRGKRZSA-N 2-[(2r)-3-chloro-2-hydroxy-2-methylpropoxy]isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(OC[C@@](O)(CCl)C)C(=O)C2=C1 MKAAKNSKKFKNRJ-LBPRGKRZSA-N 0.000 description 2
- VASJTQCHQHOOFV-BQAIUKQQSA-N 2-[(2s)-2-hydroxy-3-[5-(trifluoromethyl)spiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl]propoxy]-4-[(4-methoxyphenyl)methoxy]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1COC1=CC=C(C(O)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(C=C4C3)C(F)(F)F)CC2)=C1 VASJTQCHQHOOFV-BQAIUKQQSA-N 0.000 description 2
- WVGWFFLTSGNIEE-NTISSMGPSA-N 2-[(2s)-3-(5-chlorospiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-methylbenzamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CNC(=O)C1=CC=CC=C1OC[C@@H](O)CN1CCC2(OC3=CC(Cl)=CC=C3O2)CC1 WVGWFFLTSGNIEE-NTISSMGPSA-N 0.000 description 2
- BLUSBKMMUYMITA-HKBQPEDESA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxy-2-methylpropoxy]-4-[(4-methoxyphenyl)methoxy]-n-methylbenzamide Chemical compound C1=C(OC[C@@](C)(O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)C(C(=O)NC)=CC=C1OCC1=CC=C(OC)C=C1 BLUSBKMMUYMITA-HKBQPEDESA-N 0.000 description 2
- KZKMLWNOMSOSNT-LMOVPXPDSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxybenzoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC(O)=CC=C1C(O)=O KZKMLWNOMSOSNT-LMOVPXPDSA-N 0.000 description 2
- ASSKVPFEZFQQNQ-UHFFFAOYSA-N 2-benzoxazolinone Chemical compound C1=CC=C2OC(O)=NC2=C1 ASSKVPFEZFQQNQ-UHFFFAOYSA-N 0.000 description 2
- IGBVGNAAAJWEAD-UHFFFAOYSA-N 2-hydroxy-4-[(4-methoxyphenyl)methoxy]-n-methylbenzamide Chemical compound C1=C(O)C(C(=O)NC)=CC=C1OCC1=CC=C(OC)C=C1 IGBVGNAAAJWEAD-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- BYDRTKVGBRTTIT-UHFFFAOYSA-N 2-methylprop-2-en-1-ol Chemical compound CC(=C)CO BYDRTKVGBRTTIT-UHFFFAOYSA-N 0.000 description 2
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 2
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 2
- MWWNNNAOGWPTQY-UHFFFAOYSA-N 3-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(S(Cl)(=O)=O)=C1 MWWNNNAOGWPTQY-UHFFFAOYSA-N 0.000 description 2
- BPTFOBVMRZHCBV-HXUWFJFHSA-N 4-[(4-methoxyphenyl)methoxy]-n-methyl-2-[[(2s)-2-methyloxiran-2-yl]methoxy]benzamide Chemical compound C1=C(OC[C@@]2(C)OC2)C(C(=O)NC)=CC=C1OCC1=CC=C(OC)C=C1 BPTFOBVMRZHCBV-HXUWFJFHSA-N 0.000 description 2
- VWYYXVDWNZSPQY-LMOVPXPDSA-N 4-fluoro-2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]benzoic acid;hydrochloride Chemical compound Cl.C([C@@H](O)CN1CCC2(OC3=CC=C(F)C=C3C2)CC1)OC1=CC(F)=CC=C1C(O)=O VWYYXVDWNZSPQY-LMOVPXPDSA-N 0.000 description 2
- KRZDUNRRZAMQGF-UHFFFAOYSA-N 5-chloro-3'-fluorospiro[3h-1-benzofuran-2,4'-piperidine] Chemical compound FC1CNCCC11OC2=CC=C(Cl)C=C2C1 KRZDUNRRZAMQGF-UHFFFAOYSA-N 0.000 description 2
- CFXXYKNXUHGGRH-UHFFFAOYSA-N 5-chlorospiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C12=CC(Cl)=CC=C2COC21CCNCC2 CFXXYKNXUHGGRH-UHFFFAOYSA-N 0.000 description 2
- ITSJTYRBZNVBQP-UHFFFAOYSA-N 5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-carboxylic acid Chemical compound C1CN(C(=O)O)CCC11OC2=CC=C(Cl)C=C2C1 ITSJTYRBZNVBQP-UHFFFAOYSA-N 0.000 description 2
- ZUKZVXUSZUGBOH-UHFFFAOYSA-N 6-chlorospiro[1h-2-benzofuran-3,4'-piperidine] Chemical compound C=1C(Cl)=CC=C2C=1COC21CCNCC1 ZUKZVXUSZUGBOH-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 2
- 102100022718 Atypical chemokine receptor 2 Human genes 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- ATEKKHARYCGLNB-UHFFFAOYSA-N CC(C)(C)C1C(F)C(=O)CCN1C(O)=O Chemical compound CC(C)(C)C1C(F)C(=O)CCN1C(O)=O ATEKKHARYCGLNB-UHFFFAOYSA-N 0.000 description 2
- 108700012434 CCL3 Proteins 0.000 description 2
- 102000000013 Chemokine CCL3 Human genes 0.000 description 2
- SXEJKGNKIZAOHK-UHFFFAOYSA-N ClC(=O)OCC.FC=1C=CC2=C(CC3(O2)CCNCC3)C1 Chemical compound ClC(=O)OCC.FC=1C=CC2=C(CC3(O2)CCNCC3)C1 SXEJKGNKIZAOHK-UHFFFAOYSA-N 0.000 description 2
- OABOXRPGTFRBFZ-IMJSIDKUSA-N Cys-Cys Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(O)=O OABOXRPGTFRBFZ-IMJSIDKUSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 description 2
- 102000004890 Interleukin-8 Human genes 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001328813 Methles Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- DLNVAOLMTCZPMC-PPHPATTJSA-N OC(=O)C(F)(F)F.C=1C=CC=CC=1C(=O)O[C@H]1CCNC1 Chemical compound OC(=O)C(F)(F)F.C=1C=CC=CC=1C(=O)O[C@H]1CCNC1 DLNVAOLMTCZPMC-PPHPATTJSA-N 0.000 description 2
- HEUKKLNWOBHOPR-ZETCQYMHSA-N OC(=O)C1=CC=C(F)C=C1OC[C@H]1OC1 Chemical compound OC(=O)C1=CC=C(F)C=C1OC[C@H]1OC1 HEUKKLNWOBHOPR-ZETCQYMHSA-N 0.000 description 2
- 241000721454 Pemphigus Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 102100036154 Platelet basic protein Human genes 0.000 description 2
- 206010039088 Rhinitis atrophic Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- VNNOMSCGWJTLEM-SVBPBHIXSA-N [(3s)-3-hydroxypyrrolidin-1-yl]-[2-[(2s)-2-hydroxy-3-[5-(trifluoromethyl)spiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl]propoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(C=C4C3)C(F)(F)F)CC2)=CC=C1C(=O)N1C[C@@H](O)CC1 VNNOMSCGWJTLEM-SVBPBHIXSA-N 0.000 description 2
- RWPALELLYWNTCO-UHFFFAOYSA-N [1-benzyl-4-[(2-fluorophenyl)methyl]piperidin-4-yl]methanol Chemical compound C1CN(CC=2C=CC=CC=2)CCC1(CO)CC1=CC=CC=C1F RWPALELLYWNTCO-UHFFFAOYSA-N 0.000 description 2
- SKSRKBHPKZXBBW-NDEPHWFRSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-(4-hydroxypiperidin-1-yl)methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1CCC(O)CC1 SKSRKBHPKZXBBW-NDEPHWFRSA-N 0.000 description 2
- ZUSJKYLNDWQTMG-SXOMAYOGSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[(3r)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1C[C@H](O)CC1 ZUSJKYLNDWQTMG-SXOMAYOGSA-N 0.000 description 2
- ZUSJKYLNDWQTMG-SVBPBHIXSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1C[C@@H](O)CC1 ZUSJKYLNDWQTMG-SVBPBHIXSA-N 0.000 description 2
- IJGOHBDVNNLFGT-UIOOFZCWSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[(4s)-4-hydroxy-1,2-oxazolidin-2-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1OC[C@@H](O)C1 IJGOHBDVNNLFGT-UIOOFZCWSA-N 0.000 description 2
- OLFPPOKIKKWYPF-GPNIZQGCSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1CC(C(F)(F)F)CC1 OLFPPOKIKKWYPF-GPNIZQGCSA-N 0.000 description 2
- MLZBHFNCUHYQRA-KAWNSFPOSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[3-hydroxy-3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1CC(O)(C(F)(F)F)CC1 MLZBHFNCUHYQRA-KAWNSFPOSA-N 0.000 description 2
- MGZSDOSEYPKHPL-MHZLTWQESA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-morpholin-4-ylmethanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1CCOCC1 MGZSDOSEYPKHPL-MHZLTWQESA-N 0.000 description 2
- LNALWNNMIQXNNI-NDEPHWFRSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-piperidin-1-ylmethanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1CCCCC1 LNALWNNMIQXNNI-NDEPHWFRSA-N 0.000 description 2
- JBEGHDZUOMMNRW-MHZLTWQESA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-pyrrolidin-1-ylmethanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1CCCC1 JBEGHDZUOMMNRW-MHZLTWQESA-N 0.000 description 2
- SKMHDAKGTJZWQD-SVBPBHIXSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[(3s)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(CC2)C2=CC=C(Cl)C=C2CO3)=CC=C1C(=O)N1C[C@@H](O)CC1 SKMHDAKGTJZWQD-SVBPBHIXSA-N 0.000 description 2
- FLTJZUBYHAYDSM-LJQANCHMSA-N [4-acetamido-3-[[(2s)-2-methyloxiran-2-yl]methoxy]phenyl] benzoate Chemical compound C1=C(OC[C@@]2(C)OC2)C(NC(=O)C)=CC=C1OC(=O)C1=CC=CC=C1 FLTJZUBYHAYDSM-LJQANCHMSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000002975 chemoattractant Substances 0.000 description 2
- 238000004296 chiral HPLC Methods 0.000 description 2
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 2
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 108010035886 connective tissue-activating peptide Proteins 0.000 description 2
- PMHQVHHXPFUNSP-UHFFFAOYSA-M copper(1+);methylsulfanylmethane;bromide Chemical compound Br[Cu].CSC PMHQVHHXPFUNSP-UHFFFAOYSA-M 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 108010004073 cysteinylcysteine Proteins 0.000 description 2
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- AGGMUFZXAAWSSV-UHFFFAOYSA-N ethyl 1-benzyl-4-[(2-fluorophenyl)methyl]piperidine-4-carboxylate Chemical compound C1CN(CC=2C=CC=CC=2)CCC1(C(=O)OCC)CC1=CC=CC=C1F AGGMUFZXAAWSSV-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 2
- 229940096397 interleukin-8 Drugs 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- ZICRWXFGZCVTBZ-UHFFFAOYSA-N methyl 2-hydroxy-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C=C1O ZICRWXFGZCVTBZ-UHFFFAOYSA-N 0.000 description 2
- YQCFUMFXEPULSH-UHFFFAOYSA-N methyl 2-hydroxy-4-trityloxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1OC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 YQCFUMFXEPULSH-UHFFFAOYSA-N 0.000 description 2
- YAACVMGQEZFIDF-QMMMGPOBSA-N methyl 4-fluoro-2-[[(2s)-oxiran-2-yl]methoxy]benzoate Chemical compound COC(=O)C1=CC=C(F)C=C1OC[C@H]1OC1 YAACVMGQEZFIDF-QMMMGPOBSA-N 0.000 description 2
- FWVVYIBOMRGUOT-UHFFFAOYSA-N methyl 5-chloro-2,4-dihydroxybenzoate Chemical compound COC(=O)C1=CC(Cl)=C(O)C=C1O FWVVYIBOMRGUOT-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- PHOAIOPTKPVQOB-UHFFFAOYSA-N n-(2-hydroxy-4-methoxyphenyl)acetamide Chemical compound COC1=CC=C(NC(C)=O)C(O)=C1 PHOAIOPTKPVQOB-UHFFFAOYSA-N 0.000 description 2
- HLRHQQAQHBXWCG-UHFFFAOYSA-N n-[2-hydroxy-5-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC(C(F)(F)F)=CC=C1O HLRHQQAQHBXWCG-UHFFFAOYSA-N 0.000 description 2
- RPWRAXXBNMKUBB-VIFPVBQESA-N n-[4-chloro-2-[[(2s)-oxiran-2-yl]methoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C=C1OC[C@H]1OC1 RPWRAXXBNMKUBB-VIFPVBQESA-N 0.000 description 2
- YTBIANIUMHVGLD-NDEPHWFRSA-N n-cyclopropyl-2-[[(2s)-oxiran-2-yl]methoxy]-4-trityloxybenzamide Chemical compound C=1C=C(OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)C=C(OC[C@H]2OC2)C=1C(=O)NC1CC1 YTBIANIUMHVGLD-NDEPHWFRSA-N 0.000 description 2
- MZPSMEYDVUNPGI-UHFFFAOYSA-N n-cyclopropyl-2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzamide Chemical compound C1=CC(OC)=CC=C1COC(C=C1O)=CC=C1C(=O)NC1CC1 MZPSMEYDVUNPGI-UHFFFAOYSA-N 0.000 description 2
- MEROEZHMNPZANR-UHFFFAOYSA-N n-cyclopropyl-2-hydroxy-4-trityloxybenzamide Chemical compound C=1C=C(C(=O)NC2CC2)C(O)=CC=1OC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 MEROEZHMNPZANR-UHFFFAOYSA-N 0.000 description 2
- XYNZOQAPGUNBDC-QMMMGPOBSA-N n-methyl-2-[[(2s)-oxiran-2-yl]methoxy]benzamide Chemical compound CNC(=O)C1=CC=CC=C1OC[C@H]1OC1 XYNZOQAPGUNBDC-QMMMGPOBSA-N 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 150000002927 oxygen compounds Chemical group 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229960000581 salicylamide Drugs 0.000 description 2
- 239000012363 selectfluor Substances 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical class [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- QVKNICXDNWDLFN-UHFFFAOYSA-N spiro[1,3-benzodioxole-2,4'-piperidine] Chemical compound C1CNCCC21OC1=CC=CC=C1O2 QVKNICXDNWDLFN-UHFFFAOYSA-N 0.000 description 2
- BYGRWGNUWGBFRX-UHFFFAOYSA-N spiro[2,4-dihydrochromene-3,4'-piperidine] Chemical compound C1CNCCC21CC1=CC=CC=C1OC2 BYGRWGNUWGBFRX-UHFFFAOYSA-N 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- ULSBMKGFFFMGOI-UHFFFAOYSA-N tert-butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC11OC1 ULSBMKGFFFMGOI-UHFFFAOYSA-N 0.000 description 2
- RGMLHCFFVWGOJT-UHFFFAOYSA-N tert-butyl 3-(trifluoromethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C(F)(F)F)C1 RGMLHCFFVWGOJT-UHFFFAOYSA-N 0.000 description 2
- LTDRQRZCMHBRKM-UHFFFAOYSA-N tert-butyl 3-hydroxy-3-(trifluoromethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(O)(C(F)(F)F)C1 LTDRQRZCMHBRKM-UHFFFAOYSA-N 0.000 description 2
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- BRLQWZUYTZBJKN-GSVOUGTGSA-N (+)-Epichlorohydrin Chemical compound ClC[C@@H]1CO1 BRLQWZUYTZBJKN-GSVOUGTGSA-N 0.000 description 1
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical compound ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 description 1
- YILMPTWYTJBHCV-UHFFFAOYSA-N (2-methyl-1,3-benzoxazol-6-yl) acetate Chemical compound CC(=O)OC1=CC=C2N=C(C)OC2=C1 YILMPTWYTJBHCV-UHFFFAOYSA-N 0.000 description 1
- AVAWMINJNRAQFS-ZCFIWIBFSA-N (3r)-n,n-dimethylpyrrolidin-3-amine Chemical compound CN(C)[C@@H]1CCNC1 AVAWMINJNRAQFS-ZCFIWIBFSA-N 0.000 description 1
- JHHZLHWJQPUNKB-SCSAIBSYSA-N (3r)-pyrrolidin-3-ol Chemical compound O[C@@H]1CCNC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 1
- AVAWMINJNRAQFS-LURJTMIESA-N (3s)-n,n-dimethylpyrrolidin-3-amine Chemical compound CN(C)[C@H]1CCNC1 AVAWMINJNRAQFS-LURJTMIESA-N 0.000 description 1
- WIVSYZMURJLVCY-QWRGUYRKSA-N (3s)-n-[5-chloro-2-[[(2s)-oxiran-2-yl]methoxy]phenyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound C1[C@@H](O)CCN1C(=O)NC1=CC(Cl)=CC=C1OC[C@H]1OC1 WIVSYZMURJLVCY-QWRGUYRKSA-N 0.000 description 1
- SJLOHOMZLSZWJT-UHFFFAOYSA-N (4-acetamido-3-hydroxyphenyl) benzoate Chemical compound C1=C(O)C(NC(=O)C)=CC=C1OC(=O)C1=CC=CC=C1 SJLOHOMZLSZWJT-UHFFFAOYSA-N 0.000 description 1
- NXLNNXIXOYSCMB-UHFFFAOYSA-N (4-nitrophenyl) carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(OC(Cl)=O)C=C1 NXLNNXIXOYSCMB-UHFFFAOYSA-N 0.000 description 1
- WBDGGIYZBHZWKO-PGMHMLKASA-N (4r)-4-methyl-1,2-oxazolidin-4-ol;hydrochloride Chemical compound Cl.C[C@@]1(O)CNOC1 WBDGGIYZBHZWKO-PGMHMLKASA-N 0.000 description 1
- NYWYGQAJSIVNGV-QTNFYWBSSA-N (4s)-1,2-oxazolidin-4-ol;dihydrochloride Chemical compound Cl.Cl.O[C@H]1CNOC1 NYWYGQAJSIVNGV-QTNFYWBSSA-N 0.000 description 1
- LLCWGQYEQKYRDO-DFWYDOINSA-N (4s)-1,2-oxazolidin-4-ol;hydrochloride Chemical compound Cl.O[C@H]1CNOC1 LLCWGQYEQKYRDO-DFWYDOINSA-N 0.000 description 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 1
- UNROYLKRQDUXFX-UHFFFAOYSA-N (tert-butylazaniumyl)boron(1-) Chemical compound [B-][NH2+]C(C)(C)C UNROYLKRQDUXFX-UHFFFAOYSA-N 0.000 description 1
- NYXUPHFFAZGRJF-UHFFFAOYSA-N 1'-benzyl-5-chlorospiro[2-benzofuran-3,4'-piperidine]-1-one Chemical compound C12=CC(Cl)=CC=C2C(=O)OC1(CC1)CCN1CC1=CC=CC=C1 NYXUPHFFAZGRJF-UHFFFAOYSA-N 0.000 description 1
- VPIMKFBEIYHOIS-UHFFFAOYSA-N 1'-benzyl-6-chlorospiro[2-benzofuran-3,4'-piperidine]-1-one Chemical compound C=1C(Cl)=CC=C2C=1C(=O)OC2(CC1)CCN1CC1=CC=CC=C1 VPIMKFBEIYHOIS-UHFFFAOYSA-N 0.000 description 1
- NVWOLLRKVYNQBA-UHFFFAOYSA-N 1'-benzyl-6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine] Chemical compound C1CC2=CC(Cl)=CC=C2OC1(CC1)CCN1CC1=CC=CC=C1 NVWOLLRKVYNQBA-UHFFFAOYSA-N 0.000 description 1
- YUMXNFQGXIUSKT-UHFFFAOYSA-N 1'-benzyl-6-chlorospiro[3h-chromene-2,4'-piperidine]-4-one Chemical compound C1C(=O)C2=CC(Cl)=CC=C2OC1(CC1)CCN1CC1=CC=CC=C1 YUMXNFQGXIUSKT-UHFFFAOYSA-N 0.000 description 1
- LEEANUDEDHYDTG-UHFFFAOYSA-N 1,2-dimethoxypropane Chemical compound COCC(C)OC LEEANUDEDHYDTG-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- FFWQLZFIMNTUCZ-UHFFFAOYSA-N 1-(bromomethyl)-2-fluorobenzene Chemical compound FC1=CC=CC=C1CBr FFWQLZFIMNTUCZ-UHFFFAOYSA-N 0.000 description 1
- ZQGDSZPGKPJABN-UHFFFAOYSA-N 1-(chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane Chemical compound C1C[N+]2(CCl)CC[N+]1(F)CC2 ZQGDSZPGKPJABN-UHFFFAOYSA-N 0.000 description 1
- NWJSQYDYACROJZ-UHFFFAOYSA-N 1-benzyl-3-[(5-chloro-2-fluorophenyl)methyl]pyrrolidin-3-ol Chemical compound C1CN(CC=2C=CC=CC=2)CC1(O)CC1=CC(Cl)=CC=C1F NWJSQYDYACROJZ-UHFFFAOYSA-N 0.000 description 1
- WMUQWAIHTZUAFE-UHFFFAOYSA-N 1-benzyl-4-[(2-fluoro-5-methylphenyl)methyl]piperidin-4-ol Chemical compound CC1=CC=C(F)C(CC2(O)CCN(CC=3C=CC=CC=3)CC2)=C1 WMUQWAIHTZUAFE-UHFFFAOYSA-N 0.000 description 1
- LIULASDYZLVSSL-UHFFFAOYSA-N 1-benzyl-4-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]piperidin-4-ol Chemical compound C1CN(CC=2C=CC=CC=2)CCC1(O)CC1=CC(C(F)(F)F)=CC=C1F LIULASDYZLVSSL-UHFFFAOYSA-N 0.000 description 1
- BPPZXJZYCOETDA-UHFFFAOYSA-N 1-benzylpiperidin-4-ol Chemical compound C1CC(O)CCN1CC1=CC=CC=C1 BPPZXJZYCOETDA-UHFFFAOYSA-N 0.000 description 1
- DHGMDHQNUNRMIN-UHFFFAOYSA-N 1-benzylpyrrolidin-3-one Chemical compound C1C(=O)CCN1CC1=CC=CC=C1 DHGMDHQNUNRMIN-UHFFFAOYSA-N 0.000 description 1
- XSYHMSHUWRWMNS-LMOVPXPDSA-N 2-[(2S)-3-(5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-fluorobenzoic acid hydrochloride Chemical compound C1CN(CCC12CC3=C(O2)C=CC(=C3)Cl)C[C@@H](COC4=C(C=CC(=C4)F)C(=O)O)O.Cl XSYHMSHUWRWMNS-LMOVPXPDSA-N 0.000 description 1
- FWAJATGNWWXRIV-IHOKFDBFSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,3'-pyrrolidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]-n-methylbenzamide Chemical compound C1=C(OC[C@@H](O)CN2CC3(CC2)OC2=CC=C(Cl)C=C2C3)C(C(=O)NC)=CC=C1OCC1=CC=C(OC)C=C1 FWAJATGNWWXRIV-IHOKFDBFSA-N 0.000 description 1
- HKTSDYKQOAJBDZ-VWLOTQADSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-[(4-methoxyphenyl)methoxy]propoxy]benzoic acid Chemical compound C1=CC(OC)=CC=C1CO[C@@H](CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)COC1=CC=CC=C1C(O)=O HKTSDYKQOAJBDZ-VWLOTQADSA-N 0.000 description 1
- DTLCFHZEJSXAEO-QHCPKHFHSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]benzoic acid Chemical compound C1=CC(OC)=CC=C1COC1=CC=C(C(O)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1 DTLCFHZEJSXAEO-QHCPKHFHSA-N 0.000 description 1
- UZAVZIQUGBKVTG-BQAIUKQQSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1COC1=CC=C(C(O)=O)C(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1 UZAVZIQUGBKVTG-BQAIUKQQSA-N 0.000 description 1
- UUKFDHMPCZEPAS-VWLOTQADSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxy-n-[2-hydroxy-5-(2-methylbutan-2-yl)phenyl]benzamide Chemical compound CCC(C)(C)C1=CC=C(O)C(NC(=O)C=2C(=CC(O)=CC=2)OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C1 UUKFDHMPCZEPAS-VWLOTQADSA-N 0.000 description 1
- LCLUDKXJJLEOOL-RMRYJAPISA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-(2h-tetrazol-5-yl)benzamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1C(=O)NC=1N=NNN=1 LCLUDKXJJLEOOL-RMRYJAPISA-N 0.000 description 1
- LWJMOTCHVIUYIJ-QHCPKHFHSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-n-phenylbenzamide Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LWJMOTCHVIUYIJ-QHCPKHFHSA-N 0.000 description 1
- KWAGCAOLSIYQAN-LMOVPXPDSA-N 2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]benzoic acid;hydrochloride Chemical compound Cl.C([C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1)OC1=CC=CC=C1C(O)=O KWAGCAOLSIYQAN-LMOVPXPDSA-N 0.000 description 1
- UYNMISPPHAZJQS-DEOSSOPVSA-N 2-[(2s)-3-(5-fluorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]-n-methylbenzamide Chemical compound C1=C(OC[C@@H](O)CN2CCC3(OC4=CC=C(F)C=C4C3)CC2)C(C(=O)NC)=CC=C1OCC1=CC=C(OC)C=C1 UYNMISPPHAZJQS-DEOSSOPVSA-N 0.000 description 1
- CJIQBSLQMDOREM-DEOSSOPVSA-N 2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]-n-methylbenzamide Chemical compound C1=C(OC[C@@H](O)CN2CCC3(CC2)C2=CC=C(Cl)C=C2CO3)C(C(=O)NC)=CC=C1OCC1=CC=C(OC)C=C1 CJIQBSLQMDOREM-DEOSSOPVSA-N 0.000 description 1
- QLRKALMVPCQTMU-UHFFFAOYSA-N 2-bromo-1-fluoro-4-methylbenzene Chemical compound CC1=CC=C(F)C(Br)=C1 QLRKALMVPCQTMU-UHFFFAOYSA-N 0.000 description 1
- YFFUYGSLQXVHMB-UHFFFAOYSA-N 2-bromo-4-chloro-1-fluorobenzene Chemical compound FC1=CC=C(Cl)C=C1Br YFFUYGSLQXVHMB-UHFFFAOYSA-N 0.000 description 1
- JIQXVIJARQLCOY-UHFFFAOYSA-N 2-bromo-4-fluoro-1-methoxybenzene Chemical compound COC1=CC=C(F)C=C1Br JIQXVIJARQLCOY-UHFFFAOYSA-N 0.000 description 1
- OQBMJMJZMDBQSM-UHFFFAOYSA-N 2-bromo-5-fluorobenzoic acid Chemical compound OC(=O)C1=CC(F)=CC=C1Br OQBMJMJZMDBQSM-UHFFFAOYSA-N 0.000 description 1
- SVDDJQGVOFZBNX-UHFFFAOYSA-N 2-chloroethyl carbonochloridate Chemical compound ClCCOC(Cl)=O SVDDJQGVOFZBNX-UHFFFAOYSA-N 0.000 description 1
- BCKXMQIYWWTZDP-UHFFFAOYSA-N 2-hydroxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=CC=C1O BCKXMQIYWWTZDP-UHFFFAOYSA-N 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- ULRPISSMEBPJLN-UHFFFAOYSA-N 2h-tetrazol-5-amine Chemical compound NC1=NN=NN1 ULRPISSMEBPJLN-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- PLQLGPQFZLVKTF-UHFFFAOYSA-N 3-(trifluoromethyl)pyrrolidin-3-ol Chemical compound FC(F)(F)C1(O)CCNC1 PLQLGPQFZLVKTF-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- JLAKCHGEEBPDQI-UHFFFAOYSA-N 4-(4-fluorobenzyl)piperidine Chemical compound C1=CC(F)=CC=C1CC1CCNCC1 JLAKCHGEEBPDQI-UHFFFAOYSA-N 0.000 description 1
- ACTRYRFAWMHZOF-UHFFFAOYSA-N 4-O-tert-butyl 2-O-methyl morpholine-2,4-dicarboxylate iodomethane Chemical compound CI.N1(CC(OCC1)C(=O)OC)C(=O)OC(C)(C)C ACTRYRFAWMHZOF-UHFFFAOYSA-N 0.000 description 1
- LGWMTRPJZFEWCX-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxycarbonyl]morpholine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCOC(C(O)=O)C1 LGWMTRPJZFEWCX-UHFFFAOYSA-N 0.000 description 1
- FQPRUMXSHZSJGM-WEVVVXLNSA-N 4-[(E)-N-hydroxy-C-methylcarbonimidoyl]benzene-1,3-diol Chemical compound C\C(=N/O)C1=C(O)C=C(O)C=C1 FQPRUMXSHZSJGM-WEVVVXLNSA-N 0.000 description 1
- SHZGYYKFFZXIQW-KRWDZBQOSA-N 4-amino-3-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenol Chemical compound NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 SHZGYYKFFZXIQW-KRWDZBQOSA-N 0.000 description 1
- RYOFCFHYQKBXNO-RMRYJAPISA-N 4-amino-3-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenol;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 RYOFCFHYQKBXNO-RMRYJAPISA-N 0.000 description 1
- JFQLRCIZGQAJTK-RMRYJAPISA-N 4-amino-3-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]phenol;dihydrochloride Chemical compound Cl.Cl.NC1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 JFQLRCIZGQAJTK-RMRYJAPISA-N 0.000 description 1
- WWOBYPKUYODHDG-UHFFFAOYSA-N 4-chlorocatechol Chemical compound OC1=CC=C(Cl)C=C1O WWOBYPKUYODHDG-UHFFFAOYSA-N 0.000 description 1
- SWKNIUKAHOTPBA-LMOVPXPDSA-N 4-fluoro-2-[(2S)-2-hydroxy-3-spiro[3H-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]benzoic acid hydrochloride Chemical compound Cl.FC1=CC(=C(C(=O)O)C=C1)OC[C@H](CN1CCC2(CC1)OC1=C(C2)C=CC=C1)O SWKNIUKAHOTPBA-LMOVPXPDSA-N 0.000 description 1
- WZMLFFZQTCOHNX-KRWDZBQOSA-N 4-fluoro-2-[(2s)-2-hydroxy-3-spiro[3h-1-benzofuran-2,4'-piperidine]-1'-ylpropoxy]benzoic acid Chemical compound C([C@@H](O)CN1CCC2(OC3=CC=CC=C3C2)CC1)OC1=CC(F)=CC=C1C(O)=O WZMLFFZQTCOHNX-KRWDZBQOSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- JDQXJUOGKGSSIV-FTBISJDPSA-N 5-chloro-2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1COC1=CC(OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=C(C(O)=O)C=C1Cl JDQXJUOGKGSSIV-FTBISJDPSA-N 0.000 description 1
- LEIMSEVHOMFDOX-QRPNPIFTSA-N 5-chloro-3H-1,3-benzoxazol-2-one (3S)-N-(5-chloro-2-hydroxyphenyl)-3-hydroxypyrrolidine-1-carboxamide Chemical compound ClC=1C=CC2=C(NC(O2)=O)C1.ClC=1C=CC(=C(C1)NC(=O)N1C[C@H](CC1)O)O LEIMSEVHOMFDOX-QRPNPIFTSA-N 0.000 description 1
- HBOGHEOBSVCORG-UHFFFAOYSA-N 5-chlorospiro[1,3-benzodioxole-2,4'-piperidine] Chemical compound O1C2=CC(Cl)=CC=C2OC21CCNCC2 HBOGHEOBSVCORG-UHFFFAOYSA-N 0.000 description 1
- KJKHFQBTYMJFNP-UHFFFAOYSA-N 6-benzyl-1-oxa-6-azaspiro[2.5]octane Chemical compound C=1C=CC=CC=1CN(CC1)CCC21CO2 KJKHFQBTYMJFNP-UHFFFAOYSA-N 0.000 description 1
- SNCSIJMBJBJOMN-UHFFFAOYSA-N 6-chlorospiro[3,4-dihydrochromene-2,4'-piperidine];hydrochloride Chemical compound Cl.C1CC2=CC(Cl)=CC=C2OC21CCNCC2 SNCSIJMBJBJOMN-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- XGHKBIQVGFONLZ-PPHPATTJSA-N C(C)(=O)NC1=C(C=C(C=C1)OC)O.COC1=CC(=C(C=C1)NC(C)=O)OC[C@H]1OC1 Chemical compound C(C)(=O)NC1=C(C=C(C=C1)OC)O.COC1=CC(=C(C=C1)NC(C)=O)OC[C@H]1OC1 XGHKBIQVGFONLZ-PPHPATTJSA-N 0.000 description 1
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 1
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 1
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 1
- 102100037853 C-C chemokine receptor type 4 Human genes 0.000 description 1
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
- 102100036305 C-C chemokine receptor type 8 Human genes 0.000 description 1
- 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 1
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
- 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
- 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
- 102100034871 C-C motif chemokine 8 Human genes 0.000 description 1
- 101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 description 1
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 1
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
- 102000001902 CC Chemokines Human genes 0.000 description 1
- 108010040471 CC Chemokines Proteins 0.000 description 1
- JBARMNGZMQWEBU-UHFFFAOYSA-N CC1=NC2=C(O1)C=C(C=C2)C3=CC=CC=C3C(=O)O Chemical compound CC1=NC2=C(O1)C=C(C=C2)C3=CC=CC=C3C(=O)O JBARMNGZMQWEBU-UHFFFAOYSA-N 0.000 description 1
- 108050006947 CXC Chemokine Proteins 0.000 description 1
- 102000019388 CXC chemokine Human genes 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000001326 Chemokine CCL4 Human genes 0.000 description 1
- 108010055165 Chemokine CCL4 Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- SITRKAFGRQCARM-FYZYNONXSA-N ClC=1C=CC2=C(CC3(CCNCC3)O2)C1.C(C)(=O)NC1=C(C=C(C=C1)OC)OC[C@H](CN1CCC2(CC1)OC1=C(C2)C=C(C=C1)Cl)O Chemical compound ClC=1C=CC2=C(CC3(CCNCC3)O2)C1.C(C)(=O)NC1=C(C=C(C=C1)OC)OC[C@H](CN1CCC2(CC1)OC1=C(C2)C=C(C=C1)Cl)O SITRKAFGRQCARM-FYZYNONXSA-N 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 206010011416 Croup infectious Diseases 0.000 description 1
- 206010011686 Cutaneous vasculitis Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 206010014954 Eosinophilic fasciitis Diseases 0.000 description 1
- 102100023688 Eotaxin Human genes 0.000 description 1
- 101710139422 Eotaxin Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 208000027445 Farmer Lung Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
- 101000777558 Homo sapiens C-C chemokine receptor type 10 Proteins 0.000 description 1
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
- 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 description 1
- 101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 description 1
- 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 description 1
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000003838 Idiopathic interstitial pneumonia Diseases 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 108010018951 Interleukin-8B Receptors Proteins 0.000 description 1
- 206010024227 Lepromatous leprosy Diseases 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
- 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 102000014962 Monocyte Chemoattractant Proteins Human genes 0.000 description 1
- 108010064136 Monocyte Chemoattractant Proteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- HEECKBKPUKBOIE-UHFFFAOYSA-N OC1=C(C=CC(=C1)O)C(C)=O.OC1=C(C=CC(=C1)O)C(C)=N/O Chemical compound OC1=C(C=CC(=C1)O)C(C)=O.OC1=C(C=CC(=C1)O)C(C)=N/O HEECKBKPUKBOIE-UHFFFAOYSA-N 0.000 description 1
- LHXCNNJCOJJNMV-YDALLXLXSA-N ON1C(C=2C(C1=O)=CC=CC2)=O.C[C@@]2(OC2)CON2C(C1=CC=CC=C1C2=O)=O Chemical compound ON1C(C=2C(C1=O)=CC=CC2)=O.C[C@@]2(OC2)CON2C(C1=CC=CC=C1C2=O)=O LHXCNNJCOJJNMV-YDALLXLXSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 208000033464 Reiter syndrome Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 1
- 208000036284 Rhinitis seasonal Diseases 0.000 description 1
- GOOHAUXETOMSMM-VKHMYHEASA-N S-propylene oxide Chemical compound C[C@H]1CO1 GOOHAUXETOMSMM-VKHMYHEASA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000009359 Sezary Syndrome Diseases 0.000 description 1
- 208000021388 Sezary disease Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- IJGOHBDVNNLFGT-IZZNHLLZSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-[(4-methoxyphenyl)methoxy]phenyl]-[(4r)-4-hydroxy-1,2-oxazolidin-2-yl]methanone Chemical compound C1=CC(OC)=CC=C1COC(C=C1OC[C@@H](O)CN2CCC3(OC4=CC=C(Cl)C=C4C3)CC2)=CC=C1C(=O)N1OC[C@H](O)C1 IJGOHBDVNNLFGT-IZZNHLLZSA-N 0.000 description 1
- DKSPFLAKYGWMLX-RQTGTWPESA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-(dimethylamino)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1[C@H](N(C)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 DKSPFLAKYGWMLX-RQTGTWPESA-N 0.000 description 1
- OSKZSGVIVGPGHZ-ONBNZSDASA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3r)-3-propan-2-ylpyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1[C@@H](C(C)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 OSKZSGVIVGPGHZ-ONBNZSDASA-N 0.000 description 1
- QRISUYWARARGGC-GMAHTHKFSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]methanone Chemical compound C1[C@@H](N(C)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 QRISUYWARARGGC-GMAHTHKFSA-N 0.000 description 1
- DKSPFLAKYGWMLX-CPTHQKRGSA-N [2-[(2s)-3-(5-chlorospiro[3h-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]methanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1[C@@H](N(C)C)CCN1C(=O)C1=CC=C(O)C=C1OC[C@@H](O)CN1CCC2(OC3=CC=C(Cl)C=C3C2)CC1 DKSPFLAKYGWMLX-CPTHQKRGSA-N 0.000 description 1
- SSEMXJZFAWHOHJ-QFIPXVFZSA-N [2-[(2s)-3-(6-chlorospiro[1h-2-benzofuran-3,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-(4-fluoropiperidin-1-yl)methanone Chemical compound C([C@@H](O)CN1CCC2(CC1)C1=CC=C(Cl)C=C1CO2)OC1=CC(O)=CC=C1C(=O)N1CCC(F)CC1 SSEMXJZFAWHOHJ-QFIPXVFZSA-N 0.000 description 1
- XYMGFGLYSHSVHV-UHFFFAOYSA-N [3-(trifluoromethyl)pyrrolidin-3-yl] 2,2,2-trifluoroacetate Chemical compound FC(C(=O)OC1(CNCC1)C(F)(F)F)(F)F XYMGFGLYSHSVHV-UHFFFAOYSA-N 0.000 description 1
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000010085 airway hyperresponsiveness Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 208000017760 chronic graft versus host disease Diseases 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010549 croup Diseases 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- KJOZJSGOIJQCGA-UHFFFAOYSA-N dichloromethane;2,2,2-trifluoroacetic acid Chemical compound ClCCl.OC(=O)C(F)(F)F KJOZJSGOIJQCGA-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XEBCWEDRGPSHQH-YUMQZZPRSA-N dipropan-2-yl (2s,3s)-2,3-dihydroxybutanedioate Chemical compound CC(C)OC(=O)[C@@H](O)[C@H](O)C(=O)OC(C)C XEBCWEDRGPSHQH-YUMQZZPRSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 201000001564 eosinophilic gastroenteritis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000024711 extrinsic asthma Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- OSTIHFXUTPZJQL-UHFFFAOYSA-N fluoro benzoate Chemical compound FOC(=O)C1=CC=CC=C1 OSTIHFXUTPZJQL-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 208000008585 mastocytosis Diseases 0.000 description 1
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- YNLMJEPXHLXGRQ-CYBMUJFWSA-N methyl 2-[(4r)-4-hydroxy-4-methyl-1,2-oxazolidine-2-carbonyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1C(=O)N1OC[C@](C)(O)C1 YNLMJEPXHLXGRQ-CYBMUJFWSA-N 0.000 description 1
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 description 1
- UITFCFWKYAOJEJ-UHFFFAOYSA-N methyl 2-hydroxy-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C=C1O UITFCFWKYAOJEJ-UHFFFAOYSA-N 0.000 description 1
- SWKKKZKIPZOMBG-UHFFFAOYSA-N methyl 3-nitrobenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 SWKKKZKIPZOMBG-UHFFFAOYSA-N 0.000 description 1
- QIFPNTBBJWONGY-INIZCTEOSA-N methyl 4-[(4-methoxyphenyl)methoxy]-2-[[(2s)-oxiran-2-yl]methoxy]benzoate Chemical compound C1=C(OC[C@H]2OC2)C(C(=O)OC)=CC=C1OCC1=CC=C(OC)C=C1 QIFPNTBBJWONGY-INIZCTEOSA-N 0.000 description 1
- WPWUDDDJTIZBGL-UHFFFAOYSA-N methyl 4-fluoro-2-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(F)C=C1O WPWUDDDJTIZBGL-UHFFFAOYSA-N 0.000 description 1
- KAMBKLSZKIKCFU-UHFFFAOYSA-N methyl 5-chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate Chemical compound C1=C(O)C(C(=O)OC)=CC(Cl)=C1OCC1=CC=C(OC)C=C1 KAMBKLSZKIKCFU-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- SVIBTDFEQRRZHA-UHFFFAOYSA-N morpholin-2-ylmethyl 2,2,2-trifluoroacetate 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC(F)(F)C(=O)OCC1CNCCO1 SVIBTDFEQRRZHA-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 201000005962 mycosis fungoides Diseases 0.000 description 1
- DAKZISABEDGGSV-UHFFFAOYSA-N n-(2-aminoethyl)acetamide Chemical compound CC(=O)NCCN DAKZISABEDGGSV-UHFFFAOYSA-N 0.000 description 1
- IDRLAUZNCJICQG-UHFFFAOYSA-N n-(2-hydroxy-4-methoxyphenyl)acetamide;5-methoxy-2-nitrophenol Chemical compound COC1=CC=C([N+]([O-])=O)C(O)=C1.COC1=CC=C(NC(C)=O)C(O)=C1 IDRLAUZNCJICQG-UHFFFAOYSA-N 0.000 description 1
- DCKCNXPTCOPTIJ-UHFFFAOYSA-N n-(4-chloro-2-hydroxyphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C=C1O DCKCNXPTCOPTIJ-UHFFFAOYSA-N 0.000 description 1
- CTAHPJBINCBZPP-UHFFFAOYSA-N n-(5-chloro-2-hydroxy-4-methoxyphenyl)acetamide Chemical compound COC1=CC(O)=C(NC(C)=O)C=C1Cl CTAHPJBINCBZPP-UHFFFAOYSA-N 0.000 description 1
- HDCCJUCOIKLZNM-LURJTMIESA-N n-[(3s)-pyrrolidin-3-yl]acetamide Chemical compound CC(=O)N[C@H]1CCNC1 HDCCJUCOIKLZNM-LURJTMIESA-N 0.000 description 1
- TZZHHYPBZAQPHS-VIFPVBQESA-N n-[4-fluoro-2-[[(2s)-oxiran-2-yl]methoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(F)C=C1OC[C@H]1OC1 TZZHHYPBZAQPHS-VIFPVBQESA-N 0.000 description 1
- NDCCGPOCESCESX-CYBMUJFWSA-N n-[4-methoxy-2-[[(2s)-2-methyloxiran-2-yl]methoxy]phenyl]acetamide Chemical compound COC1=CC=C(NC(C)=O)C(OC[C@@]2(C)OC2)=C1 NDCCGPOCESCESX-CYBMUJFWSA-N 0.000 description 1
- CEDJIUFKFIHTGR-VIFPVBQESA-N n-[5-chloro-2-[[(2s)-oxiran-2-yl]methoxy]phenyl]acetamide Chemical compound CC(=O)NC1=CC(Cl)=CC=C1OC[C@H]1OC1 CEDJIUFKFIHTGR-VIFPVBQESA-N 0.000 description 1
- OHPZUWWMXRFBAU-QMMMGPOBSA-N n-[5-chloro-4-methoxy-2-[[(2s)-oxiran-2-yl]methoxy]phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC[C@H]2OC2)=C1NC(C)=O OHPZUWWMXRFBAU-QMMMGPOBSA-N 0.000 description 1
- 125000006126 n-butyl sulfonyl group Chemical group 0.000 description 1
- XIUNRBROKOTTLP-UHFFFAOYSA-N n-cyclopropyl-2-hydroxy-4-methoxybenzamide Chemical compound OC1=CC(OC)=CC=C1C(=O)NC1CC1 XIUNRBROKOTTLP-UHFFFAOYSA-N 0.000 description 1
- UWYBOEZQGCFECQ-UHFFFAOYSA-N n-cyclopropyl-2-hydroxybenzamide Chemical compound OC1=CC=CC=C1C(=O)NC1CC1 UWYBOEZQGCFECQ-UHFFFAOYSA-N 0.000 description 1
- PENMCZVLHSRKCH-UHFFFAOYSA-N n-cyclopropyl-4-fluoro-2-(oxiran-2-ylmethoxy)benzamide Chemical compound C1OC1COC1=CC(F)=CC=C1C(=O)NC1CC1 PENMCZVLHSRKCH-UHFFFAOYSA-N 0.000 description 1
- TULLAVUHMWCRFQ-UHFFFAOYSA-N n-cyclopropyl-4-fluoro-2-hydroxybenzamide Chemical compound OC1=CC(F)=CC=C1C(=O)NC1CC1 TULLAVUHMWCRFQ-UHFFFAOYSA-N 0.000 description 1
- OUORJZNGTUQIEL-NSHDSACASA-N n-cyclopropyl-4-methoxy-2-[[(2s)-oxiran-2-yl]methoxy]benzamide Chemical compound C([C@H]1OC1)OC1=CC(OC)=CC=C1C(=O)NC1CC1 OUORJZNGTUQIEL-NSHDSACASA-N 0.000 description 1
- 125000006137 n-hexyl sulfonyl group Chemical group 0.000 description 1
- 125000006129 n-pentyl sulfonyl group Chemical group 0.000 description 1
- 125000006124 n-propyl sulfonyl group Chemical group 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- AIHIHVZYAAMDPM-UHFFFAOYSA-N oxiran-2-ylmethyl 3-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=CC=CC(S(=O)(=O)OCC2OC2)=C1 AIHIHVZYAAMDPM-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 208000002574 reactive arthritis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- RNMPNVBLQHYANU-UHFFFAOYSA-N spiro[2-benzofuran-3,4'-piperidine]-1-one Chemical compound C12=CC=CC=C2C(=O)OC21CCNCC2 RNMPNVBLQHYANU-UHFFFAOYSA-N 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- NYSYYGRFAKETOP-ZDUSSCGKSA-N tert-butyl (3s)-3-benzoyloxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC[C@@H]1OC(=O)C1=CC=CC=C1 NYSYYGRFAKETOP-ZDUSSCGKSA-N 0.000 description 1
- APCBTRDHCDOPNY-ZETCQYMHSA-N tert-butyl (3s)-3-hydroxypyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC[C@H](O)C1 APCBTRDHCDOPNY-ZETCQYMHSA-N 0.000 description 1
- ACBXCQNAUDQLNT-JTQLQIEISA-N tert-butyl 2-[[(2s)-oxiran-2-yl]methoxy]benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=C1OC[C@H]1OC1 ACBXCQNAUDQLNT-JTQLQIEISA-N 0.000 description 1
- GOJBKVCBCDNHJR-UHFFFAOYSA-N tert-butyl 4-[(5-fluoro-2-methoxyphenyl)methyl]-4-hydroxypiperidine-1-carboxylate Chemical compound COC1=CC=C(F)C=C1CC1(O)CCN(C(=O)OC(C)(C)C)CC1 GOJBKVCBCDNHJR-UHFFFAOYSA-N 0.000 description 1
- ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YRYSAWZMIRQUBO-UHFFFAOYSA-N trimethylsulfoxonium Chemical compound C[S+](C)(C)=O YRYSAWZMIRQUBO-UHFFFAOYSA-N 0.000 description 1
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- 208000001319 vasomotor rhinitis Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0202133A SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Novel compounds |
| PCT/SE2003/001185 WO2004005295A1 (en) | 2002-07-08 | 2003-07-07 | Novel tricyclic spiropiperidines or spiropyrrolidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005537255A true JP2005537255A (ja) | 2005-12-08 |
| JP2005537255A5 JP2005537255A5 (enExample) | 2006-08-31 |
Family
ID=20288470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004519472A Pending JP2005537255A (ja) | 2002-07-08 | 2003-07-07 | 新規三環式スピロピペリジンまたはスピロピロリジン |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7449475B2 (enExample) |
| EP (1) | EP1521757B1 (enExample) |
| JP (1) | JP2005537255A (enExample) |
| CN (2) | CN1974574A (enExample) |
| AR (1) | AR040475A1 (enExample) |
| AT (1) | ATE385235T1 (enExample) |
| AU (1) | AU2003243122B2 (enExample) |
| BR (1) | BR0312560A (enExample) |
| CA (1) | CA2492122A1 (enExample) |
| CY (1) | CY1107915T1 (enExample) |
| DE (1) | DE60318948T2 (enExample) |
| DK (1) | DK1521757T3 (enExample) |
| ES (1) | ES2298575T3 (enExample) |
| IS (1) | IS7662A (enExample) |
| MX (1) | MXPA05000278A (enExample) |
| NO (1) | NO20050635L (enExample) |
| NZ (1) | NZ537259A (enExample) |
| PL (1) | PL374877A1 (enExample) |
| PT (1) | PT1521757E (enExample) |
| RU (1) | RU2320664C2 (enExample) |
| SE (1) | SE0202133D0 (enExample) |
| TW (1) | TW200413386A (enExample) |
| UA (1) | UA77809C2 (enExample) |
| WO (1) | WO2004005295A1 (enExample) |
| ZA (1) | ZA200500024B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007217288A (ja) * | 2006-02-14 | 2007-08-30 | Chisso Corp | 液晶化合物、液晶組成物および液晶表示素子 |
| JP2010534670A (ja) * | 2007-07-24 | 2010-11-11 | ブリストル−マイヤーズ スクイブ カンパニー | ケモカイン受容体活性のモジュレーターとしてのピペリジン誘導体 |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
| EP1661889A4 (en) | 2003-09-05 | 2009-08-05 | Ono Pharmaceutical Co | ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES |
| US20070021498A1 (en) * | 2004-10-14 | 2007-01-25 | Nafizal Hossain | Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| SE0302755D0 (sv) * | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel compounds |
| SE0302811D0 (sv) * | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
| SE0303090D0 (sv) * | 2003-11-20 | 2003-11-20 | Astrazeneca Ab | Novel compounds |
| SE0303280D0 (sv) * | 2003-12-05 | 2003-12-05 | Astrazeneca Ab | Novel compounds |
| SE0303541D0 (sv) * | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | New compounds |
| TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| WO2006012226A2 (en) | 2004-06-24 | 2006-02-02 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
| CN101193862B (zh) | 2005-04-13 | 2013-08-21 | 阿斯特克斯治疗有限公司 | 羟基苯甲酰胺衍生物和其作为hsp90抑制剂的用途 |
| WO2007028638A1 (en) | 2005-09-09 | 2007-03-15 | Euro-Celtique S.A. | Fused and spirocycle compounds and the use thereof |
| US7754725B2 (en) | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
| MX2009000475A (es) * | 2006-07-19 | 2009-07-10 | Astrazeneca Ab | Nuevos compuestos de espiropiperidina triciclicos, su sintesis y sus usos como moduladores de la actividad de los receptores de quimioquinas. |
| JP5518478B2 (ja) | 2006-10-12 | 2014-06-11 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
| JP5721949B2 (ja) | 2006-10-12 | 2015-05-20 | アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | 複合薬剤 |
| US8883790B2 (en) | 2006-10-12 | 2014-11-11 | Astex Therapeutics Limited | Pharmaceutical combinations |
| US8916552B2 (en) | 2006-10-12 | 2014-12-23 | Astex Therapeutics Limited | Pharmaceutical combinations |
| JP5410285B2 (ja) | 2006-10-12 | 2014-02-05 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
| GB0620259D0 (en) | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| ES2627221T3 (es) | 2006-12-28 | 2017-07-27 | Rigel Pharmaceuticals, Inc. | Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso |
| EP2120935A4 (en) * | 2007-02-23 | 2011-06-22 | Astrazeneca Ab | NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA |
| US20110136843A1 (en) * | 2007-02-23 | 2011-06-09 | Tomas Eriksson | Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma |
| WO2008121066A1 (en) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors |
| TW200904423A (en) * | 2007-06-20 | 2009-02-01 | Glaxo Group Ltd | Spiroindolines as modulators of chemokine receptors |
| WO2009011653A1 (en) * | 2007-07-17 | 2009-01-22 | Astrazeneca Ab | A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds |
| WO2009011655A1 (en) * | 2007-07-17 | 2009-01-22 | Astrazeneca Ab | Splropiperidine compounds, a process of their preparation, pharmaceutical compositions containing them, and their use in the treatment of airway diseases, inflammatory diseases, copd or asthma |
| EP2190286A4 (en) * | 2007-08-14 | 2011-06-01 | Glaxo Group Ltd | SPIROINDENES AND SPIROINDANES AS MODULATORS OF CHEMOKINE RECEPTORS |
| WO2009061881A1 (en) * | 2007-11-07 | 2009-05-14 | Glaxo Group Limited | Spirodihydrobenzofurans as modulators of chemokine receptors |
| EP2250176B1 (en) * | 2008-01-30 | 2012-08-01 | Cephalon, Inc. | Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| FR2928150A1 (fr) | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
| GB0806527D0 (en) | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| EP2145891A1 (en) | 2008-07-09 | 2010-01-20 | Vetoquinol S.A. | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| AR078948A1 (es) * | 2009-11-30 | 2011-12-14 | Lilly Co Eli | Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes |
| EP3233799B1 (en) | 2014-12-19 | 2021-05-19 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
| EP3233077B1 (en) | 2014-12-19 | 2026-05-06 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
| WO2019034697A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS |
| EP4093731A1 (en) | 2020-01-20 | 2022-11-30 | Neophore Limited | Isoindoline derivatives which bind to an atp binding site |
| GB202008201D0 (en) * | 2020-06-01 | 2020-07-15 | Neophore Ltd | Inhibitor compounds |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54145660A (en) * | 1978-04-14 | 1979-11-14 | Hoechst Ag | Spiro*dihydrobenzofurannpiperidine or pyrrolidine* compound and its derivative |
| JPH06263737A (ja) * | 1992-12-11 | 1994-09-20 | Merck & Co Inc | 成長ホルモンの放出を促進するスピロピペリジン及び同族体 |
| JPH08505880A (ja) * | 1993-01-28 | 1996-06-25 | メルク エンド カンパニー インコーポレーテッド | タキキニン受容体拮抗薬としてのスピロ置換アザ環式化合物 |
| JPH09512016A (ja) * | 1994-04-14 | 1997-12-02 | メルク エンド カンパニー インコーポレーテッド | α１Ｃアドレナリン受容体拮抗薬 |
| WO1998025605A1 (en) * | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
| WO2000014086A1 (en) * | 1998-09-04 | 2000-03-16 | Millenium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| JP2001508798A (ja) * | 1997-01-21 | 2001-07-03 | メルク エンド カンパニー インコーポレーテッド | ケモカインレセプター活性のモジュレーターとしての３，３−二置換ピペリジン類 |
| WO2001064213A1 (en) * | 2000-03-02 | 2001-09-07 | Smithkline Beecham Corporation | Compounds and methods |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4010201A (en) * | 1974-04-12 | 1977-03-01 | The Upjohn Company | Organic compounds |
| US4166119A (en) * | 1978-04-14 | 1979-08-28 | American Hoechst Corporation | Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines |
| US4263317A (en) * | 1979-09-06 | 1981-04-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s |
| US5366986A (en) | 1988-04-15 | 1994-11-22 | T Cell Sciences, Inc. | Compounds which inhibit complement and/or suppress immune activity |
| DE3930262A1 (de) | 1989-09-11 | 1991-03-21 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| PT828728E (pt) | 1995-05-18 | 2003-06-30 | Altana Pharma Ag | Di-hidrobenzofuranos de fenilo |
| US5931917A (en) * | 1996-09-26 | 1999-08-03 | Verifone, Inc. | System, method and article of manufacture for a gateway system architecture with system administration information accessible from a browser |
| US5962462A (en) * | 1996-12-13 | 1999-10-05 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
| CN1290251A (zh) | 1998-02-04 | 2001-04-04 | 万有制药株式会社 | N－酰基环胺衍生物 |
| US6151675A (en) * | 1998-07-23 | 2000-11-21 | Tumbleweed Software Corporation | Method and apparatus for effecting secure document format conversion |
| US6212640B1 (en) * | 1999-03-25 | 2001-04-03 | Sun Microsystems, Inc. | Resources sharing on the internet via the HTTP |
| US6226752B1 (en) * | 1999-05-11 | 2001-05-01 | Sun Microsystems, Inc. | Method and apparatus for authenticating users |
| WO2001030780A2 (en) | 1999-10-27 | 2001-05-03 | Cor Therapeutics, Inc. | Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
| US7017175B2 (en) * | 2001-02-02 | 2006-03-21 | Opentv, Inc. | Digital television application protocol for interactive television |
| WO2002102387A1 (en) | 2001-06-18 | 2002-12-27 | H. Lundbeck A/S | Treatment of neuropathic pain |
| AU2002363236A1 (en) | 2001-10-30 | 2003-05-12 | Millennium Pharmaceuticals, Inc. | Compounds, pharmaceutical compositions and methods of use therefor |
| SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
| AU2003284984B2 (en) | 2002-10-30 | 2008-10-23 | Merck Sharp & Dohme Corp. | Gamma-aminoamide modulators of chemokine receptor activity |
| WO2004050024A2 (en) * | 2002-11-27 | 2004-06-17 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| AU2003298797A1 (en) * | 2002-12-04 | 2004-06-23 | Entriq Inc. | Multiple content provider user interface |
| US7966418B2 (en) * | 2003-02-21 | 2011-06-21 | Axeda Corporation | Establishing a virtual tunnel between two computer programs |
| SE0302755D0 (sv) | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel compounds |
| US20070021498A1 (en) * | 2004-10-14 | 2007-01-25 | Nafizal Hossain | Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| SE0302811D0 (sv) | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
| SE0303090D0 (sv) | 2003-11-20 | 2003-11-20 | Astrazeneca Ab | Novel compounds |
| SE0303280D0 (sv) | 2003-12-05 | 2003-12-05 | Astrazeneca Ab | Novel compounds |
| SE0303541D0 (sv) | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | New compounds |
| WO2005092858A2 (en) | 2004-03-29 | 2005-10-06 | Pfizer Japan Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
-
2002
- 2002-07-08 SE SE0202133A patent/SE0202133D0/xx unknown
-
2003
- 2003-07-03 TW TW092118200A patent/TW200413386A/zh unknown
- 2003-07-07 US US10/520,699 patent/US7449475B2/en not_active Expired - Fee Related
- 2003-07-07 CN CNA2006101435561A patent/CN1974574A/zh active Pending
- 2003-07-07 PL PL03374877A patent/PL374877A1/xx not_active Application Discontinuation
- 2003-07-07 MX MXPA05000278A patent/MXPA05000278A/es active IP Right Grant
- 2003-07-07 CN CNB038191466A patent/CN1326858C/zh not_active Expired - Fee Related
- 2003-07-07 BR BR0312560-2A patent/BR0312560A/pt not_active IP Right Cessation
- 2003-07-07 AU AU2003243122A patent/AU2003243122B2/en not_active Ceased
- 2003-07-07 DE DE60318948T patent/DE60318948T2/de not_active Expired - Fee Related
- 2003-07-07 UA UA20041210166A patent/UA77809C2/uk unknown
- 2003-07-07 DK DK03762957T patent/DK1521757T3/da active
- 2003-07-07 CA CA002492122A patent/CA2492122A1/en not_active Abandoned
- 2003-07-07 ES ES03762957T patent/ES2298575T3/es not_active Expired - Lifetime
- 2003-07-07 AT AT03762957T patent/ATE385235T1/de not_active IP Right Cessation
- 2003-07-07 PT PT03762957T patent/PT1521757E/pt unknown
- 2003-07-07 EP EP03762957A patent/EP1521757B1/en not_active Expired - Lifetime
- 2003-07-07 JP JP2004519472A patent/JP2005537255A/ja active Pending
- 2003-07-07 RU RU2004137278/04A patent/RU2320664C2/ru not_active IP Right Cessation
- 2003-07-07 NZ NZ537259A patent/NZ537259A/en unknown
- 2003-07-07 WO PCT/SE2003/001185 patent/WO2004005295A1/en not_active Ceased
- 2003-07-08 AR AR20030102463A patent/AR040475A1/es not_active Application Discontinuation
-
2005
- 2005-01-03 ZA ZA200500024A patent/ZA200500024B/xx unknown
- 2005-01-24 IS IS7662A patent/IS7662A/is unknown
- 2005-02-04 NO NO20050635A patent/NO20050635L/no not_active Application Discontinuation
-
2008
- 2008-04-03 CY CY20081100375T patent/CY1107915T1/el unknown
- 2008-11-05 US US12/265,251 patent/US20090062322A1/en not_active Abandoned
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54145660A (en) * | 1978-04-14 | 1979-11-14 | Hoechst Ag | Spiro*dihydrobenzofurannpiperidine or pyrrolidine* compound and its derivative |
| JPH06263737A (ja) * | 1992-12-11 | 1994-09-20 | Merck & Co Inc | 成長ホルモンの放出を促進するスピロピペリジン及び同族体 |
| JPH08505880A (ja) * | 1993-01-28 | 1996-06-25 | メルク エンド カンパニー インコーポレーテッド | タキキニン受容体拮抗薬としてのスピロ置換アザ環式化合物 |
| JPH09512016A (ja) * | 1994-04-14 | 1997-12-02 | メルク エンド カンパニー インコーポレーテッド | α１Ｃアドレナリン受容体拮抗薬 |
| WO1998025605A1 (en) * | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
| JP2001508798A (ja) * | 1997-01-21 | 2001-07-03 | メルク エンド カンパニー インコーポレーテッド | ケモカインレセプター活性のモジュレーターとしての３，３−二置換ピペリジン類 |
| WO2000014086A1 (en) * | 1998-09-04 | 2000-03-16 | Millenium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| WO2001064213A1 (en) * | 2000-03-02 | 2001-09-07 | Smithkline Beecham Corporation | Compounds and methods |
Non-Patent Citations (3)
| Title |
|---|
| JPN6009058078, Ｊｏｕｒｎａｌ ｏｆ Ｍｅｄｉｃｉｎａｌ Ｃｈｅｍｉｓｔｒｙ, 2002, ４５（２）, ４９２−５０３ * |
| JPN6009058080, ＥＵＲ Ｊ． ＭＥＤ． ＣＨＥＭ．, 1996, ｖｏｌ．３１, ８８９ − ８９４ * |
| JPN6009058082, 有機合成の戦略−逆合成のノウハウ, 1998, １０−１９, 化学同人 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007217288A (ja) * | 2006-02-14 | 2007-08-30 | Chisso Corp | 液晶化合物、液晶組成物および液晶表示素子 |
| JP2010534670A (ja) * | 2007-07-24 | 2010-11-11 | ブリストル−マイヤーズ スクイブ カンパニー | ケモカイン受容体活性のモジュレーターとしてのピペリジン誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| PL374877A1 (en) | 2005-11-14 |
| SE0202133D0 (sv) | 2002-07-08 |
| EP1521757B1 (en) | 2008-01-30 |
| RU2004137278A (ru) | 2005-09-10 |
| CA2492122A1 (en) | 2004-01-15 |
| WO2004005295A1 (en) | 2004-01-15 |
| CN1675218A (zh) | 2005-09-28 |
| DE60318948D1 (de) | 2008-03-20 |
| ES2298575T3 (es) | 2008-05-16 |
| ZA200500024B (en) | 2006-02-22 |
| RU2320664C2 (ru) | 2008-03-27 |
| CN1974574A (zh) | 2007-06-06 |
| US7449475B2 (en) | 2008-11-11 |
| CY1107915T1 (el) | 2013-09-04 |
| CN1326858C (zh) | 2007-07-18 |
| UA77809C2 (en) | 2007-01-15 |
| AU2003243122A1 (en) | 2004-01-23 |
| US20050245741A1 (en) | 2005-11-03 |
| DK1521757T3 (da) | 2008-05-05 |
| PT1521757E (pt) | 2008-04-03 |
| US20090062322A1 (en) | 2009-03-05 |
| HK1074622A1 (en) | 2005-11-18 |
| AR040475A1 (es) | 2005-04-06 |
| IS7662A (is) | 2005-01-24 |
| DE60318948T2 (de) | 2009-05-20 |
| NZ537259A (en) | 2006-08-31 |
| AU2003243122B2 (en) | 2006-09-28 |
| TW200413386A (en) | 2004-08-01 |
| BR0312560A (pt) | 2005-05-10 |
| NO20050635L (no) | 2005-03-31 |
| EP1521757A1 (en) | 2005-04-13 |
| MXPA05000278A (es) | 2005-03-31 |
| ATE385235T1 (de) | 2008-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7449475B2 (en) | Tricyclic spiropiperidines or spiropyrrolidines | |
| US10717725B2 (en) | Pyrrolidine GPR40 modulators | |
| AU2001283345B2 (en) | Cyclopentyl modulators of chemokine receptor activity | |
| US20090298861A1 (en) | Novel tricyclic spiroderivatives as modulators of chemokine receptor activity | |
| US8227481B2 (en) | Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof | |
| US7498338B2 (en) | Compounds | |
| BRPI0617189A2 (pt) | derivados alfa-aminocarboxamida quarternários, composição farmacêutica contendo os mesmos, processo de preparação, bem como usos moduladores de canais de sódio dependentes de voltagem | |
| EP1699803A1 (en) | Novel compounds | |
| JP2007509052A (ja) | ケモカイン受容体活性のモジュレーターとしての新規三環式スピロ誘導体 | |
| JP2005501866A (ja) | ケモカイン受容体活性のモジュレーターとしての新規ピペリジニル誘導体 | |
| KR20050017096A (ko) | 신규한 트리시클릭 스피로피페리딘 또는 스피로피롤리딘 | |
| HK1074622B (en) | Tricyclic spiropiperidines or spiropyrrolidines | |
| MXPA06005427A (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060704 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060704 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091104 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091110 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100608 |